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Abstract
The Huntington’s disease gene (HTT) CAG repeat mutation undergoes somatic expansion that correlates with pathogenesis.
Modifiers of somatic expansion may therefore provide routes for therapies targeting the underlying mutation, an approach
that is likely applicable to other trinucleotide repeat diseases. Huntington’s disease Hdh
Q111 mice exhibit higher levels of
somatic HTT CAG expansion on a C57BL/6 genetic background (B6.Hdh
Q111) than on a 129 background (129.Hdh
Q111).
Linkage mapping in (B6x129).Hdh
Q111 F2 intercross animals identified a single quantitative trait locus underlying the strain-
specific difference in expansion in the striatum, implicating mismatch repair (MMR) gene Mlh1 as the most likely candidate
modifier. Crossing B6.Hdh
Q111 mice onto an Mlh1 null background demonstrated that Mlh1 is essential for somatic CAG
expansions and that it is an enhancer of nuclear huntingtin accumulation in striatal neurons. Hdh
Q111 somatic expansion was
also abolished in mice deficient in the Mlh3 gene, implicating MutLc (MLH1–MLH3) complex as a key driver of somatic
expansion. Strikingly, Mlh1 and Mlh3 genes encoding MMR effector proteins were as critical to somatic expansion as Msh2
and Msh3 genes encoding DNA mismatch recognition complex MutSb (MSH2–MSH3). The Mlh1 locus is highly polymorphic
between B6 and 129 strains. While we were unable to detect any difference in base-base mismatch or short slipped-repeat
repair activity between B6 and 129 MLH1 variants, repair efficiency was MLH1 dose-dependent. MLH1 mRNA and protein
levels were significantly decreased in 129 mice compared to B6 mice, consistent with a dose-sensitive MLH1-dependent
DNA repair mechanism underlying the somatic expansion difference between these strains. Together, these data identify
Mlh1 and Mlh3 as novel critical genetic modifiers of HTT CAG instability, point to Mlh1 genetic variation as the likely source
of the instability difference in B6 and 129 strains and suggest that MLH1 protein levels play an important role in driving of
the efficiency of somatic expansions.
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Introduction
Huntington’s disease (HD) is a fatal, dominantly inherited
neurodegenerative disease, which is caused by the expansion of a
CAG repeat within exon 1 of the HTT gene, resulting in an
extended glutamine tract in the huntingtin protein (HTT) [1]. The
length of the longer CAG repeat tract is the primary determinant
of age of disease onset [2]. However, precise disease expression
and timing are clearly modifiable by other factors, with strong
evidence supporting the contribution of genetic factors [3,4]. The
identification of such factors could lead to the development of
novel therapeutic interventions that modify the nature and/or
pace of the HD-associated pathogenic process, and is being
pursued via a number of candidate and global genetic approaches
[5]. The expanded HTT CAG repeat is highly unstable both in the
germline and in somatic tissues [6–13]. In somatic tissues
instability is expansion-biased and prevalent in brain regions that
are most susceptible to neurodegeneration [7]. Approximately
10% of expanded HTT CAG alleles are further expanded by at
least 10 repeats in human HD postmortem brain, with dramatic
increases of up to 1,000 repeats also occurring, albeit at a lower
frequency [7,11]. Given the strong CAG length-dependence of
disease onset and severity, somatic expansion is predicted to
accelerate the disease process. Mathematical modeling has
suggested a mechanism by which somatic expansion beyond a
threshold repeat length is required for clinical onset [14]. Whether
in fact somatic expansion beyond a typically inherited repeat
length of 40–50 CAGs is required for disease onset is unclear.
PLOS Genetics | www.plosgenetics.org 1 October 2013 | Volume 9 | Issue 10 | e1003930Nevertheless the hypothesis that somatic expansion is at least a
disease modifier is supported by the finding that longer somatic
HTT CAG expansions are associated with an earlier residual
disease onset (onset unexplained by inherited CAG length) in HD
patients [11]. These data suggest that factors that modify somatic
instability will also modify disease and could be targeted to delay
onset or progression of HD.
Identification of modifier genes in the mouse has the potential to
provide insight into disease pathways at the earliest stages of the
pathogenic process. To study mechanisms of HTT CAG instability
and pathogenesis in the mouse we have developed a series of
accurate genetic Huntington’s disease homologue (Hdh or Htt)
CAG knock-in mice [15–17] that provide powerful tools to
uncover genetic modifiers of early dominant, HTT CAG length-
dependent events. Using candidate gene knockout approaches we
have found that Msh2 and Msh3 genes, encoding a key mismatch
recognition complex designated MutSb (MSH2–MSH3 heterodi-
mer), are essential for somatic HTT CAG expansion in Hdh
Q111
knock-in mice [18–20]. Similar studies using various mouse
models of HD and other trinucleotide repeat diseases support a
central role for the mismatch repair (MMR) pathway in somatic
instability [21–28]. While the effects of MMR proteins on
instability can vary according to the repeat sequence and its
context [21–28], it is notable that Msh2 and Msh3 enhance CAG/
CTG expansion both in HD and DM1 mouse models [18–23,25–
27], and Pms2, encoding a subunit of the MutLa (MLH1-PMS2)
complex that acts downstream of mismatch recognition by MutSa
(MSH2–MSH6 heterodimer) or MutSb, was identified as a genetic
enhancer of CTG expansion in a DM1 mouse model [24]. These
observations highlight underlying similarities of the CAG/CTG
expansion process across disease loci. Importantly, in Hdh
Q111
mice Msh2 and Msh3 promote HTT CAG-dependent mutant
huntingtin diffuse nuclear localization and nuclear inclusion
phenotypes. While the relationship between instability and nuclear
huntingtin localization/inclusion phenotypes is correlative, these
data support the hypothesis that somatic expansions contribute to
an ongoing HTT CAG-dependent process [18–20].
An alternative approach for identifying modifiers in the mouse
is to take advantage of naturally occurring strain-specific
phenotypic variation. Interestingly, mouse strain-specific differ-
ences in trinucleotide repeat instability [17,22,29] and various HD
mouse model phenotypes [17,30,31] have been identified.
Notably, strain-specific differences in the instability of the HTT
CAG repeat in R6/1 transgenic mice were recently found to be
associated with polymorphisms in the Msh3 gene [29]. With the
aim of performing unbiased genetic screens for HTT CAG-
dependent phenotypes we have generated congenic Hdh
Q111 mice
on several different genetic backgrounds [17]. In a comparison of
congenic B6.Hdh
Q111, FVB.Hdh
Q111 and 129.Hdh
Q111 strains we
previously showed that intergenerational HTT CAG instability,
somatic HTT CAG instability, diffusely immunostaining nuclear
huntingtin and intranuclear inclusions in striatal neurons were
modified by genetic background [17], providing the opportunity to
perform unbiased searches for genetic modifiers of HTT CAG-
dependent events. Here, we set out to perform a genetic linkage
study with the aim of mapping genetic modifier(s) of somatic HTT
CAG instability in Hdh
Q111 mice, in order to gain further insight
into factors underlying somatic instability with the potential to
uncover novel targets for slowing somatic instability and/or early
events in the HD pathogenic process.
Results
Quantification of somatic instability in congenic Hdh
Q111
mice
Our previous qualitative analyses revealed high and low levels of
HTT CAG instability in striata from B6.Hdh
Q111/+ and
129.Hdh
Q111/+ mice, respectively, at both 10 and 20 weeks of
age [17]. At 10 weeks of age B6.Hdh
Q111/+ striata display a
broadened and expansion-biased CAG length distribution, in
contrast to 129.Hdh
Q111/+ mice that display very low levels of
somatic expansion (Figure 1A and [17]). By 20 weeks of age a
bimodal CAG length distribution is apparent in B6.Hdh
Q111/+
striata, while 129.Hdh
Q111/+ show a broadened CAG distribution
similar to that in B6.Hdh
Q111 striata at 10 weeks of age (Figure S1
and [17]). We were interested in identifying early-acting modifiers
of instability, and therefore we determined whether the difference
in instability in B6 and 129 strains at 10 weeks of age could be
captured as a quantitative trait for genetic mapping experiments.
We thus quantified a somatic ‘‘instability index’’ from Gene-
Mapper traces of PCR-amplified HTT CAG repeats from
B6.Hdh
Q111/+ and 129.Hdh
Q111/+ striata using a previously
described method [32]. In addition, given the observation of high
levels of HTT CAG instability in the liver of CD1.Hdh
Q111/+ mice
[33], we also quantified instability indices in B6.Hdh
Q111/+ and
129.Hdh
Q111/+ livers. In concordance with our previous qualitative
assessment [17], the quantification of instability in striatum and
liver of 10-week-old mice revealed significantly higher levels in
B6.Hdh
Q111/+ mice compared to 129.Hdh
Q111/+ mice (2-tailed
unpaired t-test: p,0.0001 for both striatum and liver; Figure 1B).
Note that there was a significant difference in the constitutive
CAG repeat size between these B6 and 129 mice (2-tailed
unpaired t-test: p,0.0001; Figure S2). While CAG length could, in
principle, account for at least some of the difference in instability
between strains, our previous analyses demonstrated a strain-
specific difference in instability that was unaccounted for by CAG
size alone [17], strongly indicating that identification of additional
instability modifiers would be plausible. Striatal instability indices
from the two strains were quite distinct (Figure 1B and Figure 2A),
indicating that the instability index was likely to provide a sensitive
quantitative trait for mapping genetic modifiers. Liver instability
Author Summary
The expansion of a CAG repeat underlies Huntington’s
disease (HD), with longer CAG tracts giving rise to earlier
onset and more severe disease. In individuals harboring a
CAG expansion the repeat undergoes further somatic
expansion over time, particularly in brain cells most
susceptible to disease pathogenesis. Preventing this
repeat lengthening may delay disease onset and/or slow
progression. We are using mouse models of HD to identify
the factors that modify the somatic expansion of the HD
CAG repeat, as these may provide novel targets for
therapeutic intervention. To identify genetic modifiers of
somatic expansion in HD mouse models we have used
both an unbiased genetic mapping approach in inbred
mouse strains that exhibit different levels of somatic
expansion, as well as targeted gene knockout approaches.
Our results demonstrate that: 1) Mlh1 and Mlh3 genes,
encoding components of the DNA mismatch repair
pathway, are critical for somatic CAG expansion; 2) in the
absence of somatic expansion the pathogenic process in
the mouse is slowed; 3) MLH1 protein levels are likely to be
a driver of the efficiency of somatic expansion. Together,
our data provide new insight into the factors underlying
the process of somatic expansion of the HD CAG repeat.
Mlh1 and Mlh3 Are Required for CAG Expansions
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predicting less power in the ability to identify genetic modifiers of
liver instability than striatal instability.
Identification of a quantitative trait locus associated with
somatic HTT CAG instability
Based on the findings above we used striatal instability index,
which showed very good separation between B6 and 129 strains,
as a quantitative phenotype for linkage mapping. Analyses of HTT
CAG instability in striata from (B6x129).Hdh
Q111/+ F1 mice
showed comparable instability indices to those in B6.Hdh
Q111/+
mice (2-tailed unpaired t-test: p=0.11), and significantly higher
instability indices than in 129.Hdh
Q111/+ mice (2-tailed unpaired
t-test: p,0.0001) (Figure 2A), suggesting the presence of a B6
genetic locus or loci that dominantly enhance HTT CAG
expansion. While these data were consistent with a dominant B6
modifier(s) we established an F2 intercross in order to search in an
unbiased manner for both dominant and recessive modifier
loci [34]. Instability indices were quantified from the striata of
69 10-week-old (B6x129).Hdh
Q111/+ F2 animals (Figure 2A). We
observed no correlation between constitutive CAG size and striatal
CAG instability in the F2 intercross mice (Pearson correlation:
R
2=0.011, p=0.39), implying the contribution of other genetic
factors to the difference in HTT CAG instability between the two
strains. Note that the genetic background of the region surround-
ing the Hdh
Q111 allele in both strains is 129 due to the etiology of
the targeted ES cells, ruling out the possibility of identifying cis-
acting modifiers. The F2 intercross mice were genotyped using an
initial panel of 117 SNPs that distinguishes B6 and 129 strains
(Figure S3 and Table S1). Linkage analysis identified a single
quantitative trait locus (QTL) on chromosome 9 associated with
striatal HTT CAG instability with a peak LOD score of
approximately 11 (Figure S4). Notably, the MMR gene Mlh1 is
located within this interval (Figure S5). As MMR genes Msh2 and
Msh3 had been previously established as modifiers of somatic CAG
repeat expansion in Hdh
Q111 mice [18–20], additional members of
this pathway would be strongly indicated as potential modifiers. In
an attempt to primarily enhance resolution at this QTL, but also
to specifically investigate the Mlh1 gene, we genotyped the F2
animals for 10 additional markers distributed across the QTL
region, including two markers located within the Mlh1 gene
(Figure S3 and Table S1). We also genotyped additional markers
to improve overall genome coverage and specifically the coverage
of the Msh2 and Msh3 genes. Subsequent linkage analysis that
included these additional markers (total 147 SNPs) not only
confirmed the mapping of a single QTL on chromosome 9
(Figure 3), but also significantly narrowed down the implicated
genomic region to an interval of approximately 5 Mb
(chr9:107,982,655–113,057,967; GRCm38/mm10) (Figure S6).
This genomic region, which represents a 95% confidence interval,
is defined by the markers encompassing a 2-LOD drop-off from
the peak LOD score [35]. Interestingly, the markers at the Mlh1
locus defined the QTL peak, which was significantly increased to a
LOD score of approximately 14 (Figure 3 and Figure S6). We did
not find any evidence for linkage to the Msh2 or Msh3 genes on
chromosomes 17 and 13, respectively (Figure 2B and Figure 3).
Note that constitutive CAG repeat lengths in the F2 mice did not
cluster with genotype at the Mlh1 locus (Figure S2), consistent with
the lack of correlation between constitutive CAG length and
instability index in these mice. The chromosome 9 QTL explains
approximately 60% of the variance in striatal instability, with the
remaining 40% of the variance being attributable to differences
within the parental strains, strongly supporting this locus as the
single major modifier of instability between the two strains.
Further, the effect of the QTL was consistent with the B6 allele
acting in a dominant fashion (Figure 2).
In addition to Mlh1, the implicated genomic region contains
numerous genes (Figure S6), none of which we are able to
objectively exclude as a modifier based on our genetic data.
However, none of these genes has been shown or is suspected to be
involved in repeat instability. Past observations that the MMR
pathway plays a major role in modulating somatic HTT CAG
instability, together with the highest LOD scores observed with
two markers that were located within the Mlh1 gene, strongly
suggest that this MMR gene is a likely candidate modifier
underlying the chromosome 9 QTL.
Mlh1 is a modifier of somatic HTT CAG instability and
nuclear mutant huntingtin
Based on our above findings we hypothesized that Mlh1 was a
modifier of somatic HTT CAG expansion. Therefore, to
investigate the role of the Mlh1 gene in somatic HTT CAG
expansion we crossed B6.Hdh
Q111 and Mlh1 null mice (B6) [36]
Figure 1. Somatic HTT CAG instability differs between
B6.Hdh
Q111/+ and 129.Hdh
Q111/+ mice. (A) Representative GeneMap-
per profiles of HTT CAG repeat size distributions in the tail, striatum and
liver of 10-week-old B6.Hdh
Q111/+ and 129.Hdh
Q111/+ mice, highlighting
the altered contribution of B6 and 129 genetic background to somatic
HTT CAG repeat expansion, as previously described [17]. Tail and
striatum: B6.Hdh
Q111/+, CAG116; 129.Hdh
Q111/+, CAG112. Liver:
B6.Hdh
Q111/+, CAG113; 129.Hdh
Q111/+, CAG111 (B) Quantification of
CAG instability index reveals a statistically significant decrease in
somatic HTT CAG instability in the striatum and liver of 129.Hdh
Q111/+
mice compared to B6.Hdh
Q111/+ mice. B6.Hdh
Q111/+ striatum, n=10,
CAG116.961.2SD; B6.Hdh
Q111/+ liver, n =10, CAG114.361.2SD;
129.Hdh
Q111/+ striatum, n=12, CAG110.961.2SD; 129.Hdh
Q111/+ liver,
n=9, CAG109.561.4SD; Bar graphs represent mean 6SD; ****,
p,0.0001.
doi:10.1371/journal.pgen.1003930.g001
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liver of 22-week-old B6.Hdh
Q111/+ animals on Mlh1
+/+, Mlh1
+/2
and Mlh1
2/2 genetic backgrounds (Figure 4). By 22 weeks a
bimodal repeat size distribution was apparent both in striata and
liver of Mlh1
+/+ mice, as previously shown [33]. Mlh1
+/2 mice
exhibited similar levels of instability in striatum and liver to those
in Mlh1
+/+ mice (2-tailed unpaired t-tests: striatum, p=0.30; liver,
p=0.47). However, no instability was present in either of these
tissues in Mlh1
2/2 mice (2-tailed unpaired t-test: p,0.0001
compared to Mlh1
+/+). These findings demonstrate that Mlh1 is
absolutely required for somatic HTT CAG expansions in
B6.Hdh
Q111 mice, and provide compelling evidence that genetic
differences between B6 and 129 strains at the Mlh1 gene are likely
to underlie the difference in somatic instability between these two
strains. Note that the effect of the Mlh1 knockout is to eliminate
somatic HTT expansion at 22 weeks of age, while the 129 genetic
background results in reduced somatic expansion at the same age
(Figure S1). Therefore, if Mlh1 genetic variants do indeed underlie
Figure 2. Striatal HTT CAG instability in 10-week-old Hdh
Q111/+ mice on different genetic backgrounds. Graphical representation of
striatal CAG instability indices from individual (A) B6, 129, (B6x129).F1 and (B6x129).F2 mice, color-coded based on strain genetic background; and
from (B) (B6x129).F2 mice color-coded by genotype at the Mlh1, Msh3 and Msh2 genes (‘‘undetermined’’ indicates failed genotype). F2 mice
homozygous or heterozygous for B6 Mlh1 alleles display significantly higher levels of striatal somatic CAG instability than F2 mice homozygous for
129 Mlh1 alleles (p,0.0001 for both). No relationship could be established between Msh3 or Msh2 genotype and striatal CAG instability. B6.Hdh
Q111/+,
n=10, CAG116.961.2SD; 129.Hdh
Q111/+, n=12, CAG110.961.2SD; (B6x129).Hdh
Q111/+ F1, n=11, CAG114.766.4SD; (B6x129).Hdh
Q111/+ F2, n=69,
CAG107.763.2SD. dbSNP markers located within MMR genes: Mlh1, rs30131926 and rs30174694 (concordant genotypes detected with both markers);
Msh3, rs29551174; Msh2, rs33609112 and rs49012398 (concordant genotypes detected with both markers). Horizontal bars represent the mean CAG
instability indices of the respective groups.
doi:10.1371/journal.pgen.1003930.g002
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such variants are likely to confer a moderate effect on MLH1.
We have previously shown that deletion of mismatch repair
genes Msh2 or Msh3 is sufficient to delay the accumulation/epitope
accessibility of diffusely immunostained mutant huntingtin in
the nuclei of striatal neurons [18–20]. This early phenotype,
which is both dominant and CAG length-dependent [16], is a
sensitive marker of the ongoing pathogenic process in these mice.
To determine whether Mlh1 also modified this phenotype we
quantified diffusely-immunostained nuclear huntingtin in stri-
atal sections of 22-week-old B6.Hdh
Q111/+ animals on Mlh1
+/+,
Mlh1
+/2 and Mlh1
2/2 genetic backgrounds (Figure 5). Nuclear
huntingtin immunostaining intensity was reduced in Mlh1
+/2
striata to approximately 60% of Mlh1
+/+ levels, although this
difference did not reach statistical significance (2-tailed unpaired
t-test: p=0.06). In Mlh1
2/2 striata nuclear huntingtin immuno-
staining intensity was dramatically reduced to approximately 18%
of Mlh1
+/+ levels (2-tailed unpaired t-test: p=0.0018). Together,
these findings reveal Mlh1 as a genetic enhancer both of somatic
expansion and of an early CAG length-dependent phenotype in
B6.Hdh
Q111/+ mice, supporting the hypothesis that somatic
expansion accelerates HTT CAG-dependent events.
Figure 3. Identification of a quantitative trait locus (QTL) associated with striatal HTT CAG instability. Linkage analysis in 10-week-old
(B6x129).Hdh
Q111/+ F2 mice (n=69) identified a single QTL on chromosome 9, with a maximum LOD score of approximately 14 and a 2-LOD-dropoff
interval of 5 Mb (chr9:107,982,655–113,057,967; GRCm38/mm10) (Figure S6). Note that the 2 markers positioned within the Mlh1 gene (dbSNP
rs30131926 and rs30174694) define the QTL peak. The red dashed line represents the threshold (LOD=4.3) considered for the identification of
significant QTLs [85]. The coordinates (cM) of the 147 genetic markers used are represented by open triangles.
doi:10.1371/journal.pgen.1003930.g003
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Given the critical role of MLH1 in somatic HTT CAG
expansion we were interested in investigating further this
MLH1-mediated pathway. It is known that MLH1 is an obligate
subunit of three MutL complexes: MutLa (MLH1-PMS2), MutLb
(MLH1-PMS1) and MutLc (MLH1–MLH3) (reviewed in [37,38]).
These MutL heterodimers are essential downstream factors in
MMR and are recruited to the MMR reaction following the
binding of mismatched DNA by MutSa (MSH2–MSH6) or
MutSb (MSH2–MSH3). Outside of its role in meiotic recombi-
nation [39], MutLc appears to function predominantly with
MutSb both in somatic and germ cells [40,41]. Given the specific
requirement for MutSb in somatic CAG expansion in Hdh
Q111
mice [19] and other mouse models of CAG/CTG disease
[22,25,26], we hypothesized that MLH3 may also play a major
role in somatic expansion. A role for MLH3 had also been
Figure 4. Mlh1 is required for striatal and liver HTT CAG repeat instability in B6.Hdh
Q111/+ mice. (A) Representative GeneMapper profiles of
HTT CAG repeat size distributions in the tail, striatum and liver of 22-week-old B6.Hdh
Q111/+ mice on different Mlh1 genetic backgrounds. Mlh1
+/+,
CAG113; Mlh1
+/2, CAG113; Mlh1
2/2, CAG110. (B) Quantification of striatal and liver HTT CAG instability indices in these mice reveals a statistically
significant decrease in HTT CAG instability in the absence of Mlh1. Mlh1
+/+, CAG115.364.9SD, n=6; Mlh1
+/2, CAG112.062.1SD, n=6; Mlh1
2/2,
CAG109.362.6SD, n=6. Bar graphs represent mean 6SD. ****, p,0.0001.
doi:10.1371/journal.pgen.1003930.g004
Figure 5. Mlh1 is an enhancer of nuclear mutant huntingtin immunostaining in B6.Hdh
Q111/+ mice. (A) Representative EM48
immunostained histological sections from striata of 22-week-old B6.Hdh
Q111/+ mice on different Mlh1 genetic backgrounds. Mlh1
+/+, CAG113; Mlh1
+/2,
CAG108; Mlh1
2/2, CAG110. (B) Quantification of diffuse nuclear EM48 staining demonstrates a statistically significant reduction in the absence of
Mlh1. Mlh1
+/+, CAG115.364.9SD, n=6; Mlh1
+/2, CAG112.062.1SD, n=6; Mlh1
2/2, CAG109.262.9SD, n=5. Bar graphs represent mean 6SD. **,
p,0.01.
doi:10.1371/journal.pgen.1003930.g005
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type 1 in which knockout of Pms2, encoding MLH1’s major
binding partner, reduced the rate of somatic CTG expansion by
,50%, but did not eliminate somatic expansions [24]. We
therefore crossed B6.Hdh
Q111 with Mlh3 null mice (B6) [39] and
quantified HTT CAG repeat size distributions in the tail, striatum
and liver of 24-week-old B6.Hdh
Q111/+ animals on Mlh3
+/+, Mlh3
+/
2 and Mlh3
2/2 genetic backgrounds (Figure 6). Slightly reduced
striatum- and liver-specific CAG instability was observed in
Mlh3
+/2 mice when compared to Mlh3
+/+ animals (2-tailed
unpaired t-tests: striatum, p=0.06; liver, p=0.03). Interestingly,
no instability was present in Mlh3
2/2 striatum or liver (2 tailed
unpaired t-tests: p,0.0001 for both tissues compared to Mlh3
+/+),
demonstrating, as for MLH1, that MLH3 is absolutely required
for somatic HTT CAG instability in B6.Hdh
Q111 mice, and
implying that MutLc dimers act in this process. The slight
reduction of instability in Mlh3
+/2 mice (Figure 6), not apparent in
Mlh1
+/2 mice (Figure 4) suggests that Mlh3 may be a limiting
factor in somatic expansion, as previously reported for Msh3
[19,26]. The relatively strong impacts of heterozygous loss of Mlh3
and Msh3 compared to heterozygous loss of the Mlh1 and Msh2
genes encoding their respective binding partners may be explained
in part by the lower levels of MSH3 compared to MSH2 and of
MLH3 compared to MLH1 [42,43].
The Mlh1 locus is highly polymorphic between B6 and
129 strains
While our linkage peak contained many genes, given the finding
that Mlh1 is necessary for somatic HTT CAG expansion, we
focused on this gene as the most likely candidate modifier at the
linked chromosome 9 locus. We initially investigated polymor-
phisms at the Mlh1 locus between C57BL/6NCrl and 129S2/
SvPasCrlf strains (in which the QTL mapping was carried out) by
sequencing all Mlh1 exons as well as the immediate 59 and 39
flanking regions (2.6 kb and 2 kb respectively). A relatively high
frequency of SNPs was identified in the 59UTR of Mlh1 (8 SNPs in
an 84 bp region), and a single SNP was detected in the 39UTR
(Table 1). We also identified 14 exonic SNPs, 4 of which result in
an amino acid change: F192I, E390D, G404V and M528I
(Figure 7). A subsequent investigation of the Mlh1 locus in the
highly related C57BL/6NJ and 129S1/SvImJ strains using whole
genome sequencing data from the Mouse Genomes Project
[44,45] confirmed all of the B6-129 polymorphisms initially
identified by us by Sanger sequencing. It also resulted in the
identification of a large number of additional polymorphims
between B6 and 129 strains, dispersed throughout the entire
Mlh1 locus (Table 1 and Figure S7). In total, 642 polymorphisms
were identified in a 64 kb region encompassing the Mlh1 gene,
averaging approximately 10 polymorphims per kb. In compar-
ison to the average genome wide variation between B6 and 129
strains of 2.4 polymorphisms per kb the Mlh1 gene exhibits a
high degree of variation, with only 5.9% of the genome
displaying a relative density greater than or equal to 10
polymorphism per kb (see Materials and Methods and [44]). It
is noteworthy that the haplotype across this 64 kb region in
FVB/N and DBA/2J strains that display similar high somatic
HTT CAG instability to B6 strains is highly similar to the B6
haplotype (Figure S7 and Figure S8). While this finding was
consistent with a B6-like haplotype at the Mlh1 locus underlying
Figure 6. Mlh3 is required for striatal and liver HTT CAG repeat instability in B6.Hdh
Q111/+ mice. (A) Representative GeneMapper profiles of
HTT CAG repeat size distributions in the tail, striatum and liver of 24-week-old B6.Hdh
Q111/+ mice on different Mlh3 genetic backgrounds. Mlh3
+/+,
CAG103; Mlh3
+/2, CAG101; Mlh3
2/2, CAG102. (B) Quantification of striatal and liver HTT CAG instability indices in these animals reveals a statistically
significant suppression of HTT CAG instability in the absence of Mlh3. Mlh3
+/+, CAG103.361.5SD, n=3;Mlh3
+/2, CAG101.360.5SD, n=4;Mlh3
2/2,
CAG101.360.6SD, n=3. Bar graphs represent mean 6SD. *, p,0.05; ***, p,0.001; ****, p,0.0001.
doi:10.1371/journal.pgen.1003930.g006
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haplotypes did not provide the means to further refine the
putative instability-associated region(s).
All 4 nonsynonymous SNPs are suspected to be in key protein
domains: F192I falls within the putative ATP binding domain,
though outside conserved ATP binding motifs [46]; E390D and
G404V are within a domain thought to be necessary for
interaction with MSH3 [41], and M528I is in a region implicated
in interaction with MSH3, EXOI, MLH3, PMS1 and PMS2 [41]
(Figure 7A). Note that none of these variants has been identified in
human MLH1 [47]. Cross-species alignment of MLH1 proteins
(Figure 7B) shows that the Phe residue at aa192 of the B6 MLH1
protein was fully conserved across the organisms investigated, with
an Ile residue at this position present in 129 strains. At positions
390 and 528 the B6-like amino acid is highly conserved, mainly in
higher organisms, while the 129-like amino acid at position 528 is
also well represented, particularly among lower organisms. In
contrast, aa404 is poorly conserved. While none of the SNP
variants alters the general chemical similarity of the amino acids,
the conservation data indicate that the F192I substitution may
have a functional impact. This is supported by PolyPhen-2 analysis
[48] predicting E390D, G404V and M528I to be ‘‘benign’’, but
predicting the F192I mutation to be ‘‘probably damaging’’ with a
maximum confidence score.
B6 and 129 MLH1 proteins do not differ in their intrinsic
DNA repair capacity but repair of CAG slip-outs is MLH1
dose-dependent
The highly polymorphic nature of the Mlh1 gene indicated that
delineation of the functional polymorphism(s) that drives the
difference in instability between B6 and 129 mice may well be
complex. However, based on the above prediction that at least the
F192I substitution may have a functional impact we tested the
simplest hypothesis that the B6 and 129 versions of MLH1 have
different levels of activity. As there is currently no good assay for
MutLc function, we performed cell-free assays using MutLa
(MLH1-PMS2 complexes), known to be required to repair G-T
mismatches and single repeat slip-outs of CAG/CTG tracts
[49,50], in order to provide the most sensitive test of B6 and 129
MLH1 function. We thus cloned and co-purified B6-like
(mMLH1.B6-hPMS2) and 129-like (mMLH1.129-hPMS2) MutLa
proteins (Figure S11) and assessed the ability of these proteins
(containing all 4 amino acid differences; Figure 6A) to repair
various DNA substrates using cell-free assays. The results revealed
that B6 and 129 MLH1 proteins displayed no overt difference in
their abilities to repair a G-T mismatch (Figure S12). In addition,
the human MLH1 protein carrying the F192I mutation showed
MMR activity comparable to that of wild-type human MLH1
(Figure S12). We then tested the ability of B6 and 129 MLH1
proteins to repair a single CTG slip-out (CAG)47N(CTG)48 [50,51],
a potential intermediate in the expansion process, as requirements
for processing of slipped-DNAs formed by trinucleotide repeats
may more closely resemble those that ultimately result in CAG
expansion in mice. As shown previously [50], complementation of
MLH1- and PMS2-deficient HEK293T cells with wild-type
human MutLa restored repair activity (Figure 8A). Complemen-
tation with mMLH1.B6-hPMS2 or mMLH1.129-hPMS2 MutLa
complexes also restored repair to similar efficiencies (Figure 8A).
Titration of concentration of the B6-like and 129-like MutLa
complexes confirmed similar repair efficiencies between the
MLH1 protein from the two mouse strains at each concentration
(2-tailed unpaired t-tests: 5 ng, p=0.477; 25 ng, p=0.885; 100 ng,
p=0.736), but also demonstrated a statistically significant MutLa
dose dependency of CTG slip-out repair (linear regression:
R
2=0.557, p=0.0004; Figure 8B). Together, these results
demonstrate that B6 and 129 MLH1 proteins, in the context of
the mixed-species MutLa complex, do not differ substantially in
their G-T mismatch or CTG slip-out repair activities and that the
F192I mutation in the human protein does not have a significant
functional impact. This suggests that if Mlh1 gene variations are in
fact the source of the CAG repeat instability differences between
the B6 and 129 mouse strains in vivo, this is unlikely to be due to
major differences in MLH1 protein activity within the context of
the MutLa complex. However, the dose-dependence of the
MutLa complex in the CTG slip-out repair assay indicated that
differential MLH1 protein levels between the two strains may be
relevant to their different levels of instability in vivo.
Mlh1 mRNA and protein levels are reduced in 129 versus
B6 mice
The cell-free CTG slip-out repair assays suggested that levels of
MLH1 may impact the ability of MutL complexes to execute a
repair process that results in CAG expansion in vivo. We therefore
assessed whether Mlh1 expression levels differed between the B6
and 129 strains that exhibit comparatively high and low HTT
CAG instability, respectively. Striatal Mlh1 mRNA amount was
significantly reduced in 129 mice to 54% of that in B6 mice (2-
tailed unpaired t-test: p=0.017), reaching approximately the same
mRNA level as that in B6.Mlh1
+/2 mice (Figure 9A). Striatal Mlh1
mRNA levels were consistently reduced in 129 mice across 3
distinct regions of the primary Mlh1 transcript (exons 4–5, 11–12,
and 18–19), and in various other tissues (cerebellum, liver, jejunum
and ileum) to between 25% and 50% of B6 levels (Figure S13).
Analysis of MLH1 protein by western blot showed similarly
reduced protein levels in 129 compared to B6 striata (Figure 9B,
C). In contrast to the mRNA, however, the MLH1 protein level in
B6.Mlh1
+/2 mice was intermediate between that in B6 (Mlh1
+/+)
and 129 striata (Figure 9B, C). We were unable to detect any
evidence for novel isoforms or truncation products in the 129 mice
(Figure S14).
Given the difference in Mlh1 mRNA levels between B6 and 129
strains we investigated possible polymorphisms that might underlie
this difference. As we had identified polymorphisms in both 59 and
39 regulatory regions of Mlh1 (Table 1 and Figure S7) we tested
Table 1. The Mlh1 locus is highly polymorphic between B6
and 129 strains.
Genomic region Number of polymorphisms
59 of Mlh1 (16 kb) 85
Mlh1 (43 kb) 59 UTR 8
exonic 14 (4*)
intronic 518
39 UTR 1
39 of Mlh1 (5 kb) 16
Total (64 kb) 642
*Nonsynonymous SNPs.
DNA polymorphisms (SNPs, short indels and structural variants) identified at a
64 kb region surrounding the Mlh1 locus (chr9:111,223,496–111,287,496;
GRCm38/mm10) as determined by Sanger sequencing (C57BL/6N vs. 129S2/
SvPasCrlf) and whole genome sequencing (C57BL/6NJ vs. 129S1/SvImJ)
performed as part of the Mouse Genomes Project (Wellcome Trust Sanger
Institute) [44,45]. The Mlh1 locus is highly polymorphic between B6 and 129
strains, averaging approximately 10 polymorphisms per kb (Figure S7 and [44]).
doi:10.1371/journal.pgen.1003930.t001
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and 1.7 kb, respectively) of either the B6 or 129 Mlh1 gene were
able to drive differential steady state levels of a luciferase reporter
gene (Figure 10). As shown in Figure 10A there was no significant
difference in firefly luciferase activity when either the B6 59 region
or the 129 59 region was used to drive firefly luciferase expression
(2-tailed unpaired t-test: p=0.18). In contrast, when the 39 region
was cloned downstream of the firefly luciferase gene (Figure 10B,
panel i), whose expression was driven from the SV40 promoter,
the 129 39 region resulted in a ,2-fold reduction in firefly
luciferase activity compared to the B6 39 region (2-tailed unpaired
t-test: p=0.012). These results suggest that polymorphisms in this
39 genomic region may be relevant to the ,2-fold reduction of
Mlh1 mRNA seen in vivo in 129 mice compared to B6 mice
(Figure 9). In an effort to narrow down the polymorphisms within
this region that contributed to the differential luciferase expression
we performed further luciferase reporter assays in which the 39
genomic region from either strain was either successively deleted
(Figure 10B, panels ii–iv) or in which the original 1.7 kb 39 region
from the B6 Mlh1 gene was substituted with different subdomains
of 129 genomic sequence (Figure 10B, panel v). The deletion
experiments (panels ii, iii, iv) indicated that neither the single
Figure 7. B6-129 MLH1 protein polymorphisms. (A) Schematic representation of the murine MLH1 protein showing the location of B6-129
nonsynonymous polymorphisms identified (purple triangles) and their positions relative to conserved ATP binding motifs and ATP binding domain
(dark and light red boxes, respectively) [46], as well as proposed MMR protein interaction domains (blue boxes) [41]. (B) Cross-species alignment of B6
and 129 MLH1 proteins in regions encompassing the polymorphic sites between the two strains. Protein sequence alignment was performed using
Clustal Omega [96] and visualized in Jalview [97] with BLOSUM62 color scheme: white, residue does not match the consensus residue at that position;
light blue, residue does not match the consensus residue but the two residues have a positive BLOSUM62 score; dark blue, residue matches
consensus sequence.
doi:10.1371/journal.pgen.1003930.g007
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most 4 polymorphisms (Figure 10, panel ii) contributed to the
differential firefly luciferase expression. The data indicated that
polymorphisms both in the 129 39 genomic region from 205 bp to
591 bp (panel iii) and in the genomic region from 591 bp to
1,280 bp (panels ii and iii) contributed to the 2-fold reduction in
firefly luciferase activity. The domain ‘‘swap’’ experiments (panel
v) showed partial reduction of firefly luciferase activity when each
of three B6 genomic regions was substituted with 129 sequence,
confirming the contribution of multiple 39 polymorphisms to the
differential firefly luciferase activity.
Taken together, the results of our expression analyses indicate
that genetic differences between B6 and 129 strains result in lower
steady state Mlh1 mRNA levels in 129 compared to B6 mice.
Luciferase reporter assays suggest that this may, at least in part, be
driven by a combination of polymorphisms 39 to the Mlh1 coding
region. In addition, the lower relative level of MLH1 protein in
129 versus B6.Mlh
+/2 striata despite similar Mlh1 mRNA levels
(Figure 9) further suggests that genetic differences between these
strains also act post-transcriptionally. While we currently have no
good evidence for altered protein isoforms/truncation products in
129 versus B6 mice, the high degree of variation at the Mlh1
locus suggests that mechanisms that might impact the levels of
Figure 9. Reduced MLH1 expression in 129 versus B6 mice.
Quantification of MLH1 (A) mRNA and (B, C) protein levels in the
striatum of B6.Mlh1
+/+, 129.Mlh1
+/+ and B6.Mlh1
+/2 10-week-old mice
(n=3). (A) Striatal Mlh1 mRNA levels (TaqMan Mm00503449_m1, exons
11–12) in 129.Mlh1
+/+ mice were significantly reduced by approximately
50% when compared to B6.Mlh1
+/+ (p,0.05), and were comparable to
levels in B6.Mlh1
+/2 mice. (B, C) Western blot analysis of MLH1 protein
revealed significantly reduced levels in 129.Mlh1
+/+ striata compared to
B6.Mlh1
+/+ striata. Bar graphs represent mean 6SD. *, p,0.05; **,
p,0.01.
doi:10.1371/journal.pgen.1003930.g009
Figure 8. Repair of a single CTG slip-out in a cell-free MMR
assay is MLH1 dose-dependent. (A) Short slipped-DNA repair using
HeLa or HEK293T (MutLa-deficient) whole cell extracts complemented
with equal amounts (100 ng) of purified MutLa protein complexes:
hMLH1-hPMS2, mMLH1.B6-hPMS2 or mMLH1.129-hPMS2. Both B6 and
129 MLH1 proteins show ability to repair the mismatch when in a
complex with hPMS2. The individual lanes represented are from the
same blot. (B) Repair using MutLa-deficient HEK293T cell extracts
complemented with increasing concentrations (5, 25 and 100 ng) of
either mMLH1.B6-hPMS2 or mMLH1.129-hPMS2 protein complexes.
Quantification of repair suggests that both B6 and 129 MLH1 proteins
are comparably efficient at repairing CTG slip-outs. In addition, it
suggests a MutLa dose-dependency, with higher concentrations of
mMLH1-hPMS2 resulting in higher levels of MMR activity (p=0.0013).
The individual lanes represented are from the same blot and the
experiment was reproduced three times. Bars graphs represent mean
6SD.
doi:10.1371/journal.pgen.1003930.g008
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warrant further investigation. Our data indicate, therefore, that
the low HTT CAG instability in 129 versus B6 mice may be in
part driven by reduced levels of MLH1 protein. These findings are
consistent with the strong genetic linkage of an instability modifier
to the Mlh1 gene and indicate that B6 versus 129 variants may act
in multiple ways to ultimately determine the different MLH1
protein levels in these strains.
Discussion
Here we report the first unbiased QTL mapping study in a
mouse model of Huntington’s disease, in which we have mapped a
locus that modifies the somatic expansion of the HTT CAG
repeat. Using a quantitative measure of striatal HTT CAG
instability we were able to detect a single modifier locus of large
effect using as few as 69 F2 intercross mice. These results indicate
that, depending on the number and effect size of the modifier loci,
an intercross mapping strategy in congenic Hdh
Q111 strains is a
potentially powerful approach that could be applied to identify
modifiers of a variety of HTT CAG-dependent phenotypes.
While our genetic data do not exclude a role for other gene(s)
within the linked locus as instability modifiers, the high LOD score
observed with markers positioned over the Mlh1 gene and the
knowledge that this gene is essential for somatic HTT CAG
instability provide compelling evidence that Mlh1 is the likely
genetic modifier underlying the difference in striatal HTT CAG
instability between the B6 and 129 Hdh
Q111 mice. Further
experiments would be needed to determine whether the same
QTL contributes to the difference in liver instability between B6
and 129 strains, and/or whether other genetic loci might play a
role. Two additional genes, Trex1 and Atrip, located within the 2
LOD drop-off interval, are involved in DNA repair [52,53].
However, in a comparison with two additional unstable strains,
FVB.Hdh
Q111 and DBA.Hdh
Q111 (Figure S8), we note that Trex1
and Atrip polymorphisms do not correlate with the instability
phenotype (Figure S9A, B). Further, Trex1 and Atrip striatal mRNA
levels are not significantly different in 129 and B6 strains (2-tailed
unpaired t-test: p=0.73 and p=0.43, respectively) (Figure S9C).
While these data do not rule out a role for these genes, these
observations make them less compelling candidates as the likely
modifiers of strain-specific instability. In contrast, the observation
that a ‘‘B6-like’’ haplotype at the Mlh1 locus is also shared in
unstable FVB.Hdh
Q111 and DBA.Hdh
Q111 strains (Figure S7 and
Figure S8) is consistent with the hypothesis that genetic variation
at the Mlh1 locus underlies the difference in striatal HTT CAG
instability between B6 and 129 strains. This hypothesis also
predicts that strains with a ‘‘129-like’’ Mlh1 haplotype might be
more likely to exhibit low HTT CAG instability. It is important to
note, however, that somatic instability in any particular strain
background is likely to be influenced by other genetic variation.
Notably, the Mlh3 gene (chromosome 12), found to be a modifier
of CAG instability in this study, does not show genotype
differences between B6J and 129S1 strains [44], which are closely
related to the B6N and 129S2 strains used here. Therefore, linkage
to the Mlh3 gene would not be expected in our genetic cross.
Interestingly, Msh3 gene variants were recently found to correlate
with HTT CAG instability in some strains of R6/1 transgenic mice
[29]. However, at least for the B6N and 129S2 strains in which we
have performed genome-wide QTL mapping, it is clear from the
genetic data that any polymorphisms in the Msh3 gene do not play
a significant role in driving these strain-specific differences in
somatic expansion of the Hdh
Q111 CAG repeat (Figure 2B).
To understand this further we compared non-synonymous Msh3
SNPs, proposed to underlie the difference in CAG instability
between B6 (high instability) and BALB/cJ (low instability) R6/1
mice [29], in strains (B6, 129, FVB and DBA) for which we had
quantitative measures of Hdh
Q111 striatal instability (Figure S8).
Notably B6-BALB/cJ SNPs that are present in 129 and that might
be predicted to contribute to low instability in Hdh
Q111 mice (those
in exons 2, 3 and 7) are also present in unstable FVB and DBA
strains (Figure S10A). This suggests that these SNPs are unlikely to
contribute to the differences in Hdh
Q111 CAG instability between
B6 and 129 striata. We also note a very high degree of B6 versus
BALB/cJ genetic variation relative to B6 versus 129 genetic
variation at the Msh3 locus (Figure S10B), suggesting the possibility
that the apparently complete CAG repeat stabilization in BALB/
cJ.R6/1 mice [29] is driven by a Msh3 polymorphism(s) present in
BALB/cJ but not in 129. It is also noteworthy that a single 129
allele increases the instability of the R6/1 CAG repeat in BALB/
129 heterozygotes, consistent with higher levels of MSH3 in 129
mice than in BALB/cJ mice [29]. Despite possible locus-specific
(Hdh
Q111 versus R6/1 mice) and sub-strain differences, the data
presented here and previously [29] suggest that the combination of
genetic variants in Mlh1, Msh3, and potentially other MMR genes
that are present in any particular mouse strain may determine the
rate of CAG expansion in certain tissues.
Given that MLH1 protein levels correlate with striatal
expansion in B6 and 129 strains and that the activity of MLH1-
dependent DNA repair in cell-free assays is dose-dependent, it is
more than plausible to hypothesize that the reduced levels of Mlh1
expression in 129 mice play an important role in determining the
reduced somatic CAG instability observed in Hdh
Q111 mice in this
genetic background. Given the finding that Mlh1 is an enhancer of
nuclear huntingtin immunostaining, it is also possible that the
lower levels of MLH1 in 129 mice contribute to the slowed nuclear
huntingtin and inclusion phenotypes previously identified in
129.Hdh
Q111/+ mice compared to B6.Hdh
Q111/+ mice [17]. Further
unbiased genetic studies would be needed to identify the modifier
gene(s) that contribute to these phenotypes. It is worth noting that
a number of other studies support a role for the levels or
stoichiometries of DNA repair proteins in trinucleotide repeat
instability [43,54–57].
Expression analyses of MLH1 mRNA and protein in B6 and
129 strains (Figure 9 and Figure 10) indicate that strain-specific
polymorphisms may act at both transcriptional and post-
transcriptional levels. Assuming that B6.Mlh1
+/2 and B6.Mlh1
+/+
striata display comparable levels of instability at 10 weeks of age, as
seems likely from the similar levels of instability in B6.Mlh1
+/2 and
B6.Mlh1
+/+ mice at 22 weeks of age (Figure 4), a comparison of
Figure 10. The 129 and B6 39-flanking regions of Mlh1 confer differential mRNA regulation. Investigation of the regulatory potential of B6
and 129 immediate (A) 59- and (B) 39-flanking regions of Mlh1 using dual luciferase reporter assays. (A) The immediate 59-flanking region of Mlh1
containing 17 B6-129 polymorphisms (2,441 bp) was used to drive firefly luciferase expression. (B) The immediate 39-flanking region of Mlh1 (i–iv)
containing either 19, 15, 4 or 1 B6-129 polymorphism(s) (1,676 bp, 1,280 bp, 591 bp and 205 bp, respectively) was cloned downstream of a firefly
luciferase gene. ‘‘Swap’’ constructs (v) of the immediate 39-flanking region of Mlh1 containing either 4, 5 or 10 129 polymorphisms (530 bp, 438 bp
and 708 bp, respectively; total 1676 bp) were cloned downstream of a firefly luciferase gene. Relative luciferase activity was determined by
normalization to internal Renilla luminescence and determined relative to the analogous B6 construct. B6-129 polymorphisms are represented by
open triangles. Bar graphs represent mean 6SD. *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pgen.1003930.g010
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+/+,1 2 9 . Mlh1
+/+
and B6.Mlh1
+/2 striata (Figure 1, Figure 4, Figure S1, and Figure 9)
suggests that there may be a threshold level of MLH1 protein below
which MLH1-dependent process(es) that mediate expansion are
compromised. In this scenario, MLH1 protein in B6.Mlh1
+/2 mice,
although reduced compared to that in B6.Mlh1
+/+ mice, exceeds
this threshold, with the result that the HTT CAG repeat remains
unstable. In 129 mice, the MLH1 protein level falls below the
threshold and the HTT CAG repeat is consequently stabilized.
Alternatively, it is possible that reduced MLH1 protein alone is
insufficient to explain the HTT CAG repeat stabilization in 129
mice, but that a functional alteration of the 129 protein acts in
concert with the reduced expression level to decrease HTT CAG
expansion efficiency. Although we were unable to demonstrate any
difference in activity between B6 and 129 recombinant MLH1
proteins in cell-free MMR assays (Figure 8 and Figure S12), these
assays may not be sufficiently sensitive to detect subtle alterations in
function. It is also important to note that the MMR ability ofMLH1
was only investigated in the context of MutLa-mediated repair.
Therefore, taking into account our finding that MLH3 is essential
for somatic HTT CAG instability in vivo, we cannot rule out the
hypothesis that B6 and 129 MLH1 proteins may have dissimilar
MutLc-mediated repair potential. It is also possible that MLH1
function may differ between B6 and 129 strains in other ways in vivo
that cannot be captured in the cell-free systems, e.g. altered
interaction with binding partners. Thus, while our data indicate
that MLH1 protein levels are likely to be a driving force in
determining the differential HTT CAG somatic expansion potential
in B6 and 129 strains, phenotypic comparisons between strains at
the level of MLH1 mRNA, protein and HTT CAG instability,
together with the highly polymorphic nature of the Mlh1 locus,
suggest that the genetic architecture underlying the strain-specific
differences in instability may be complex.
MLH1 has been found to play a role in CAG repeat instability
in a selectable cell-based system [58]. A functional form of MLH1,
with an intact ATPase domain, is also required to repair slipped
CAG/CTG structures in vitro [50] (Figure 8). To our knowledge no
role for MLH3 in trinucleotide repeat instability has been
previously demonstrated. Here, we show for the first time that
both Mlh1 and Mlh3 genes enhance HTT CAG expansion in a
trinucleotide repeat disease mouse model. Our data further
consolidate the critical role of MMR genes as enhancers of HTT
CAG-dependent events [18–27,29] in Hdh
Q111 mice. We were
unable to determine the effect of loss of Mlh1 or Mlh3 on
intergenerational instability of the HTT CAG repeat in Hdh
Q111
mice as Mlh1 and Mlh3 null mice are sterile [36,39]. Interestingly,
as with somatic instability, B6.Hdh
Q111 mice show a greater degree
of intergenerational CAG repeat instability than 129.Hdh
Q111 mice
[17]. Given evidence suggesting a role for MMR pathways in both
somatic and intergenerational repeat instability [18,23,59], it is
plausible that genetic variation at the Mlh1 locus also underlies the
difference in intergenerational instability between the two strains.
The mechanism(s) by which MMR proteins mediate somatic
CAG/CTG expansion is unclear. Importantly, we find that the
MutLc components, MLH1 and MLH3, are as critical to somatic
Hdh
Q111 CAG expansion as the MutSb components MSH2 and
MSH3 [18,19], suggesting that MutLc and MutSb are involved in
the same pathway that promotes CAG/CTG expansion. While a
role for proteins downstream of MutL complexes in somatic
CAG/CTG expansion has not been demonstrated to date, the
requirements for MLH1 and MLH3 indicate that the generation
of somatic Hdh
Q111 CAG expansions requires active engagement
of the MMR machinery, in contrast to a model whereby
expansions occur due to the inability of MutSb-CAG/CTG
repeat binding to execute coupling to downstream effector
functions [25,60]. Our findings also argue against MutSb-
mediated expansion arising via other pathways that are MutL-
independent, such as single strand annealing [23,61]. Our results
support previously published studies in mouse models of DM1 in
which somatic expansion of the CTG repeat was reduced in Pms2
null mice [24] or inhibited in mice deficient in MSH2’s ATPase
function, which is required for MutL complexes recruitment [27].
Recruitment of MutL complexes is a required step for subsequent
enzymatic processing of the DNA mismatch [37,38]. An essential
function of MutLa is the activation of the latent endonuclease
activity of PMS2 [62], which, interestingly, is activated by
extrahelical CAG/CTG repeats in vitro [63]. It would therefore
be of interest to determine whether MLH3’s putative endonucle-
ase domain [62] is required for CAG expansion in vivo.
The MMR pathway, as traditionally described, is employed to
repair errors that are incurred during DNA replication. However,
there is increasing evidence that MMR proteins play various roles
in the absence of DNA replication and participate in a variety of
other pathways, distinct from MMR [64–69]. Recently, a
promutagenic noncanonical MMR pathway has been described,
which occurs in multiple cell types, is independent of DNA
replication and is activated by DNA lesions rather than
mismatches [70]. The findings that MMR proteins are required
for, rather than protect against somatic CAG/CTG instability,
that repeat expansions occur in postmitotic cells [10,33,71] and
that expansions in neurons require MSH2 [20], suggest that
CAG/CTG repeat expansion may arise via a noncanonical MMR
pathway(s).
With regard to potential mechanisms of CAG expansion it is of
interest that MSH3 and MLH3 appear to play relatively minor
roles in classical MMR inasmuch as Msh3 and Mlh3 deficiencies
result in weak mutator phenotypes and relatively low cancer
predisposition phenotypes [42,72–75]. In strong contrast, loss of
either of these two proteins has a major impact on CAG/CTG
expansion. Conversely, MSH6 and PMS2 play prominent roles in
classical MMR [72–74]. However, MSH6 is either unnecessary
for, or plays a very minimal role in mediating somatic CAG/CTG
expansions [19,22,25], and knockout of Pms2 had a moderate
effect of CTG expansion in DM1 mice [24], implicating a role for
different MLH1 partners. In the present study the complete
absence of HTT CAG expansion in Hdh
Q111/+ Mlh3 null mice
argues against a role for PMS2 in generating expansions in these
mice. Further genetic crosses in both DM1 and Hdh
Q111 mice
would be needed to determine whether the relative contributions
of Pms2 and Mlh3 genes in the two mouse models depends on the
genomic locus of the repeat and/or strain background. While we
do not expect PMS2 levels to be altered in Mlh3 knockout mice
[74], additional experiments are needed in Mlh3 and Pms2
knockout mouse tissues to determine whether any compensatory
changes in PMS2 or MLH3 proteins, respectively, occur.
However, overall, the data thus far indicate that MLH3 is a more
significant player than PMS2 in CAG/CTG expansion and
suggest that CAG/CTG repeats may preferentially engage a
pathway(s) involving MutSb and MutLc complexes, as illustrated
in Figure 11.
Given the overlapping roles of MMR proteins in both DM1 and
HD mouse models [18–27,29], the findings in the present study
are predicted to be directly relevant both to DM1 and likely other
CAG/CTG repeat expansion diseases. However, subtle qualita-
tive and quantitative differences in the effects of MMR genes in
the various mouse models suggest a potential modulatory role for
the cis-sequence surrounding the repeat. In addition, proteins in
base excision repair and nucleotide excision repair pathways have
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expansion disorders [76–78]. Further studies will be needed to
determine how the various DNA repair proteins might intersect to
mediate CAG/CTG expansion and the extent to which their
effects might depend on genomic context.
In summary, we have taken both unbiased and candidate gene
approaches towards understanding the factors that underlie the
instability of the HTT CAG repeat. Unbiased linkage mapping in
congenic Hdh
Q111 mice indicated Mlh1 as a potential genetic
modifier of strain-specific HTT CAG instability. Subsequent
candidate gene approaches demonstrated both Mlh1 and Mlh3
as critical novel modifiers of HTT CAG instability. The
identification of Mlh1 and Mlh3 as modifiers of CAG instability
in Hdh
Q111 mice suggests that variation in the human MLH1 and
MLH3 genes may contribute to differences in somatic HTT CAG
expansion that occurs between HD patients [9,11]. Further, given
their minor roles in human tumorigenesis, both MLH3 and
MSH3 currently stand as the most promising targets of the MMR
proteins that have been identified as modifiers of the HTT CAG
pathogenic process to date. Further delineation of the factors
involved in somatic instability and the pathway(s) involved are
likely to increase the ability to specifically intervene in the process
of CAG/CTG expansion in HD as well as other trinucleotide
repeat disorders.
Materials and Methods
Mice
Ethics statement: All animal procedures were carried out to
minimize pain and discomfort, under approved IACUC protocols
of the Massachusetts General Hospital and Cornell University.
Congenic Hdh
Q111 strains on C57BL/6NCrl (B6N), 129S2/
SvPasCrlf (129) and FVB/NCrl (FVB) genetic backgrounds have
been previously described [17]. In addition we generated Hdh
Q111
strains on DBA/2J (DBA) and C57BL/6J (B6J) backgrounds by
repeated backcrossing of CD1.Hdh
Q111/+ mice [15] for at least 10
generations. To map genetic modifiers of somatic HTT CAG
instability we generated (B6Nx129).Hdh
Q111/+ and (B6Nx129).
Hdh
+/+ F1 mice which were subsequently intercrossed to generate
(B6Nx129).Hdh
Q111/+ F2 progeny. B6.Mlh1 knockout mice (B6N)
[36] were crossed with B6N.Hdh
Q111 mice, and B6.Mlh3 knockout
mice (B6J) [39] were crossed with B6J.Hdh
Q111 mice to generate
B6.Hdh
Q111/+ mice heterozygous for the respective DNA repair
mutation. These mice were then intercrossed to generate
B6.Hdh
Q111/+ littermates that were wild-type (+/+), heterozygous
(+/2) or homozygous mutant (2/2) for the respective DNA
repair gene. For reasons of simplicity, both B6N and B6J will be
referred to as B6 unless otherwise specified. Mlh1 knockout mice
were also generated on the 129 background by repeated
backcrossing of B6.Mlh1
+/2 mice for 4 generations. These mice
were then intercrossed to generate 129.Mlh1
+/+, 129.Mlh1
+/2 and
129.Mlh1
2/2 littermates. Animal husbandry was performed under
controlled temperature and light/dark cycles.
Genotyping and HTT CAG repeat analysis
Genomic DNA was isolated from tail biopsies at weaning for
routine genotyping analysis or from adult tissues (fresh frozen or
fixed as below) for somatic instability analysis, using the PureGene
DNA isolation kit (Qiagen). Routine genotyping was carried out as
previously described [19,36,39]. The size of the HTT CAG repeat
Figure 11. Proposed model of MutS and MutL-dependent
events leading to CAGNCTG somatic instability. CAGNCTG repeat
structures are initially recognized by the MutSb (MSH2-MSH3) complex
[25,98]. The loop in the CAGNCTG repeat tract represents a short slip-
out, previously identified as the main substrate for MMR protein-
dependent repair of CAGNCTG structures in cell free systems [50,51].
However, the nature of the putative CAGNCTG structure(s) that leads to
MutS and MutL-dependent somatic instability in vivo is unknown.
Following ATP hydrolysis by DNA-bound MutSb [27], a MutLc (MLH1–
MLH3) heterodimer is preferentially recruited to the complex (thick
arrow) over the MutLa (MLH1-PMS2) heterodimer (thin arrow). The total
absence of HTT CAG expansion in Mlh3
2/2 mice suggests that PMS2
plays no role at all in this process. However, PMS2 has been shown to
play a role in the expansion of CTG repeats in a DM1 mouse model [24],
suggesting that these events may be genetic locus and/or mouse strain
dependent. Following MutLc binding, various pathways, e.g. canonical
mismatch repair (MMR), noncanonical mismatch repair (ncMMR) and/or
other DNA repair processes may be engaged and process the repeats
such that they ultimately undergo expansion. Other members of
alternative DNA repair pathways, namely OGG1, XPA and NEIL1 have
been directly implicated in CAG/CTG somatic instability in mice [76–78],
however, how these proteins intersect with MMR protein-dependent
pathways has yet to be demonstrated.
doi:10.1371/journal.pgen.1003930.g011
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the HTT CAG repeat from the knock-in allele but does not
amplify the mouse sequence [79]. The forward primer was
fluorescently labeled with 6-FAM (Applied Biosystems) and
products were resolved using the ABI 3730xl DNA analyzer
(Applied Biosystems) with GeneScan 500 LIZ as internal size
standard (Applied Biosystems). GeneMapper v3.7 (Applied Bio-
systems) was used to generate CAG repeat size distribution traces.
Repeat size was determined from the peak with the greatest
intensity in the GeneMapper trace from the tail biopsy (‘‘main
allele’’). CAG repeat instability index was calculated as previously
described [32]. Briefly, the highest peak in each trace was used to
determine a relative threshold of 20% and peaks falling below this
threshold were excluded from analysis. Peak heights normalized to
the sum of all peak heights were multiplied by the change in CAG
length of each peak relative to the main allele size in tail. These
values were summed to generate an instability index, which
represents the mean CAG repeat length change in the population
of cells being analyzed. Statistical comparisons of instability indices
were carried out using 2-tailed unpaired t-tests.
Quantitative trait loci (QTL) mapping
Somatic CAG instability indices were determined in the
striatum of 69 10-week-old (B6x129).Hdh
Q111/+ F2 mice, as
described above. These F2 intercross mice were originally
genotyped using a panel of 117 SNPs that distinguishes between
C57BL/6J and 129S1/SvImJ strains (Figure S3 and Table S1)
[80]. An additional set of 30 SNPs was subsequently used to add
resolution to the analysis (Figure S3 and Table S1), particularly at
the chromosome 9 QTL, including two markers inside the Mlh1
gene (dbSNP rs30131926 and rs30174694); as well as to
specifically investigate the Msh2 (dbSNP rs33609112 and
rs49012398) and Msh3 (dbSNP rs29551174) genes. Linkage
analysis was performed using Mapmaker/QTL [81–84], with
striatal HTT CAG instability indices as quantitative traits. A
threshold LOD-score of 4.3 was considered for the identification
of significant QTLs [85]. A QTL 95% confidence interval was
determined by using the 2-LOD-dropoff method [35,86].
Identification and analyses of polymorphisms
Polymorphisms at the Mlh1 locus were investigated between
C57BL/6NCrl (B6N), 129S2/SvPasCrlf (129S2), FVB/NCrl
(FVB) and DBA/2J (DBA) genetic strains by standard DNA
Sanger sequencing. PCR products were generated using Taq DNA
polymerase (Qiagen) with DNA extracted from tail as template. A
combination of primer pairs (Table S2) was used to screen the
complete coding sequence of Mlh1 as well as its immediate 59 and
39 flanking regions (2.6 kb and 2 kb respectively) by sequencing
both sense and antisense strands. Polymorphisms were validated in
two animals from each genetic strain. We also utilized an online
database for the Mouse Genomes Project (http://www.sanger.ac.
uk/resources/mouse/genomes), provided by the Wellcome Trust
Sanger Institute. This database was derived from whole genome
sequencing of 17 different genetic mouse strains [44,45], including
C57BL/6NJ (B6NJ), 129S1/SvImJ (129S1), DBA/2J (DBA) and
FVB/NJ (FVB). We used this database to retrieve information on
SNPs, short indels and structural variants over a 64 kb region
encompassing the Mlh1 gene (chr9:111,223,496–111,287,496), as
well as at the Mlh3 (chr12:85,234,529–85,270,591), Msh3
(chr13:92,201,881–92,365,003), and Trex1/Atrip loci (chr9:
109,057,933–109,074,124; GRCm38/mm10 assembly). The av-
erage genome-wide variation between B6 and 129 was determined
using the total number of SNPs and indels reported in this
database (B6J versus 129S1) relative to the GRCm38/mm10
genome size (chromosomes 1–19 and X). The relative density of
polymorphisms between B6 and 129 was determined by binning
genome-wide SNPs and indels into 64 kb regions (the same size as
the Mlh1 genomic region analyzed) and the mean density of
polymorphisms/kb determined over each of the 64 kb bins. For
reasons of simplicity, both B6N and B6NJ are referred to as B6,
129S1 and 129S2 are referred to as 129, and FVB/NCrl and
FVB/NJ are referred to as FVB, unless otherwise specified.
Immunohistochemistry
Immunostaining was carried out with polyclonal anti-huntingtin
antibody EM48 [87] on 7 mm paraffin-embedded coronal sec-
tions of periodate-lysine-paraformaldehyde (PLP)-perfused mouse
brains, as previously described [17]. Diffuse EM48 immunostain-
ing was quantified as a ‘‘staining index’’ that captures both the
nuclear staining intensity and the number of immunostained
nuclei, as described previously [17]. Statistical comparisons of
staining indices were carried out using 2-tailed unpaired t-tests.
Cell-free mismatch repair assays
Total RNA was isolated from the striatum of wild-type B6 and
129 mice using Trizol (Life Technologies) by mechanical grinding
with disposable pestle and cDNA was then prepared using the
SuperScript III First-Strand Synthesis SuperMix for qRT-PCR
(Invitrogen). Full-length Mlh1 cDNAs were amplified by PCR (for
primers used see Table S2) using Phusion High-Fidelity DNA
polymerase (New England Biolabs), and were subsequently cloned
between the unique NcoI and XhoI sites of a modified pFastBac1
baculovirus expression vector [88], so that the resulting recombi-
nant MLH1 proteins would carry N-terminal FLAG and 6xHis
epitope tags. Mlh1 cDNA pFastBac1 constructs were fully verified
by DNA sequence analysis confirming the presence of all B6-129
SNPs (for primers used see Table S2). The wild-type human
MLH1 cDNA (hMLH1-WT) baculovirus expression vector [49]
was used to generate a mutant hMLH1 cDNA construct carrying
the 129-like Ile residue at aa192 (hMLH1-F192I) by site directed
mutagenesis. Mouse and human recombinant MLH1 proteins
were independently co-expressed with human PMS2 and purified
using a baculovirus expression system to near homogeneity (Figure
S11), as previously described [49]. Protein concentrations were
determined spectrophotometrically and confirmed by polyacryl-
amide gel electrophoresis (PAGE). Repair of a single base
mismatch by MLH1 was investigated as previously described
[49]. In essence, repair of single base mismatch (G-T) substrate
containing a 59 nick was assessed using HeLa or MutLa-deficient
HCT116 [89] nuclear protein extracts (100 ng) complemented
with equal amounts of purified MutLa protein complexes:
hMLH1.WT-hPMS2, hMLH1.F192I-hPMS2, mMLH1.B6-hPMS2
or mMLH1.129-hPMS2 (100 ng). Note that as mMLH1-hPMS2
was functional in this well-established human-based assay, consistent
with previous mixed yeast-human MMR assays [90–92], we
compared B6 and 129 MLH1 proteins in a mixed mouse-human
MutLa complex, avoiding the need to introduce mouse PMS2 as
another assay variable. Single base mismatch repair was analyzed by
agarose gel electrophoresis followed by ethidium bromide staining
[49]. Repair of a single trinucleotide repeat slip-out by MLH1 was
investigated as previously described [50]. In summary, repair of single
CTG slip-out substrates (CAG)47N(CTG)48 containing a 59 nick was
assessed using HeLa or MutLa-deficient HEK293T [42,93] whole
cell extracts (120–180 ng) complemented with equal amounts of
purified hMLH1.WT-hPMS2, mMLH1.B6-hPMS2 or mMLH1.
129-hPMS2 complexes (100 ng), or with increasing amounts of
mMLH1.B6-hPMS2 or mMLH1.129-hPMS2 complexes (5, 25 and
100 ng). This experiment with increasing concentrations was
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Southern blotting. For both MMR assays, intensity of fragments was
determined by densitometry and repair activity was determined as
the intensity of repair fragments in proportion to the total intensity of
all fragments [49,50]. Statistical comparison between mMLH1.B6-
hPMS2 and mMLH1.129-hPMS2 repair efficiency was carried out
using 2-tailed unpaired t-tests. MutLa dose-dependency of CTG slip-
outs repair was determined by linear regression. The HEK293T cell
line was a gift from Dr. G. Plotz. HeLa cells were from the National
Cell Culture Center, National Center for Research Resources,
National Institutes of Health.
mRNA and protein expression analyses
mRNA and protein expression was investigated in frozen
striatum samples from 10-week-old mice (B6.Mlh1
+/+, n=3;
129.Mlh1
+/+, n=3; B6.Mlh1
+/2, n=3; and B6.Mlh1
2/2, n=1),
with the striatum from one hemisphere being used for mRNA
analysis by qRT-PCR and the other being used for protein
analysis by western blotting. Total RNA extraction and first-strand
cDNA synthesis were performed as described above. Relative
qRT-PCR was performed on a LightCycler 480 Real-Time PCR
System (Roche) using TaqMan Gene Expression Master Mix
(Applied Biosystems) and TaqMan Gene Expression Assays
(Applied Biosystems) for: Mlh1 (exons 4–5, Mm01248478_m1;
exons 11–12, Mm00503449_m1; exons 18–19, Mm00503455
_m1), Trex1 (Mm00810120_s1), and Atrip (Mm00555350_m1).
Relative mRNA expression levels were determined using the
2
2DDCp method [94] by normalization to the housekeeping gene
Actb (Mm00607939_s1). Each sample was run in triplicates and a
total of 2 runs were performed. Protein lysates were prepared in
RIPA buffer supplemented with 5 mM EDTA and protease
inhibitors (Halt Protease Inhibitor Cocktail, Thermo Scientific) by
mechanical grinding with disposable pestle and two 10-second
sonication pulses (Branson sonifier, power level 3.5), on ice. The
homogenates were kept on ice for 30 min and then clarified by
centrifugation at 4uC for 30 minutes at 14000 rpm. Protein
concentration was determined using the DC protein assay kit (Bio-
Rad). Western blot analysis was carried out by resolving protein
extracts (50 mg) on 4–12% Bis-Tris polyacrylamide gels (NuPAGE,
Life Technologies). All samples were run in the same gel and a
total of 2 gels were run. Rabbit polyclonal antibody against the C-
terminal end of MLH1 (1:200; sc-582, Santa Cruz Biotechnology)
and mouse monoclonal antibody against a-tubulin (1:1,000;
#3873, Cell Signaling Technologies) were used as primary
antibodies and horseradish peroxidase-conjugated goat anti-rabbit
and anti-mouse (1:10,000; NA934VS and NA931VS respectively,
Amersham) were used as secondary antibodies. Signals were
visualized using enhanced chemiluminescence (ECL) detection
system (Thermo Scientific). Densitometric analysis of protein levels
was performed using UN-SCAN-IT software (Silk Scientific
Corp.). Following background subtraction, MLH1 protein levels
were normalized to a-tubulin, and determined relative to
B6.Mlh1
+/+ levels. Statistical comparisons of mRNA and protein
levels were carried out using 2-tailed unpaired t-tests.
Mlh1–luciferase reporter assays
The immediate 59- and 39-flanking regions of Mlh1 were
amplified by PCR from both B6 and 129 genomic DNA (for
primers used see Table S2) using Phusion High-Fidelity DNA
polymerase (New England Biolabs). The immediate 59-flanking
region of Mlh1 (2,441 bp) was cloned upstream of the firefly
luciferase reporter in pGL4.20 (Promega) between the unique
KpnI and NheI sites. Progressively smaller segments of the
immediate 39-flanking region of Mlh1 (1,676 bp, 1,280 bp, 591 bp
and 205 bp) were cloned downstream of the firefly luciferase
reporter in pGL3-Promoter (Promega) between the unique XbaI
and BamHI sites. Additional ‘‘swap’’ constructs were also
generated for the immediate 39-flanking region of Mlh1
(1,676 bp) by dividing this region into 3 distinct subdomains (59-
39: 530 bp, 438 bp and 708 bp; using PacI and KpnI) and
replacing individual subdomains from the B6 39-flanking region of
Mlh1 with the corresponding 129 subdomain. ‘‘Swap’’ constructs
were cloned downstream of the firefly luciferase reporter in pGL3-
Promoter (Promega) at the unique XbaI site. Mlh1–luciferase
reporter constructs were fully verified by DNA sequence analysis,
confirming the presence of all B6-129 SNPs (for primers used see
Table S2). Individual Mlh1–firefly luciferase reporter constructs
were co-transfected (Lipofectamine LTX, Invitrogen) with the
Renilla luciferase reporter control pGL4.74 (Promega) into wild-
type mouse immortalized striatal cells [95]. The transfected cells
were cultured for 36–48 hours and luciferase expression was
subsequently quantified using the Dual-Luciferase Reporter Assay
System (Promega) on a microplate luminometer (MicroLumat Plus
LB96V, Berthold Technologies). Analogous B6 and 129 Mlh1–
luciferase constructs were investigated in the same experiment in
triplicate. The relative luciferase activity was calculated by
normalizing firefly luminescence to the internal Renilla signal and
determined relative to the corresponding B6 construct. Statistical
comparison of relative luciferase activity between analogous B6
and 129 Mlh1–luciferase constructs was carried out using 2-tailed
unpaired t-tests.
Supporting Information
Figure S1 Somatic HTT CAG instability in 22-week-old
B6.Hdh
Q111/+ and 129.Hdh
Q111/+ mice. Representative GeneMap-
per profiles of HTT CAG repeat size distributions in the tail and
striatum of 22-week-old B6.Hdh
Q111/+ and 129.Hdh
Q111/+ mice,
highlighting the high degree of somatic instability in B6 mice
versus the reduced contribution of the 129 genetic background to
somatic HTT CAG repeat expansions, as previously described
[17]. Tail and striatum: B6.Hdh
Q111/+, CAG112; 129.Hdh
Q111/+,
CAG110.
(TIF)
Figure S2 CAG repeat lengths of 10-week-old Hdh
Q111/+ mice
on different genetic backgrounds. Graphical representation of
CAG repeat lengths of individual mice used in this study,
grouped according to genetic background and color-coded
based on genotype. F2 mice are color-coded by Mlh1
genotype. Blue: homozygous for B6 alleles; red: homozygous
129; green: heterozygous B6/129; purple: failed genotype.
Constitutive Hdh CAG repeat lengths were determined from
tail samples. dbSNP markers located within Mlh1 gene:
rs30131926 and rs30174694 (concordant genotypes detected
with both markers). B6.Hdh
Q111/+, n=10; 129.Hdh
Q111/+,
n=12; (B6x129).Hdh
Q111/+ F1, n=11; (B6x129).Hdh
Q111/+ F2,
n=69. Horizontal bars represent the mean CAG repeat length
of respective group.
(TIF)
Figure S3 Chromosomal distribution of genetic markers used
for QTL analysis. An initial panel of 117 SNPs (green triangles)
that distinguish between B6 and 129 strains was used to perform
linkage analysis, resulting in the identification of a QTL in
chromosome 9 (Figure S4). An additional set of 30 SNPs (red
triangles) was subsequently used to enhance resolution at this QTL
and improve overall genome coverage, but also to specifically
investigate the Mlh1, Msh2 and Msh3 genetic loci (Figure 3).
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(TIF)
Figure S4 Preliminary mapping of QTL associated with striatal
CAG instability. Preliminary linkage analysis in 10-week-old
(B6x129).Hdh
Q111/+ F2 mice (n=69) identified a single QTL on
chromosome 9 with a LOD score of ,11. The red dashed line
represents the threshold (LOD=4.3) considered for the identifi-
cation of significant QTLs [85]. The coordinates (cM) of the 117
genetic markers used are represented by open triangles.
(TIF)
Figure S5 Preliminary mapping of QTL on chromosome 9
implicates numerous genes, including the MMR gene Mlh1.
Genome-wide linkage analysis using an initial set of 117 SNPs
mapped a single QTL on chromosome 9 strongly linked to striatal
CAG instability (Figure S4). A 95% confidence interval was
determined by using the 2-LOD-dropoff method [35,86],
implicating a genomic region of approximately 39 Mb (chr9:84,
495,988–123,231,477; GRCm38/mm10) that contained numer-
ous genes (,420), including the MMR gene Mlh1.
(TIF)
Figure S6 Fine-mapping of chromosome 9 QTL significantly
narrowed down the implicated genomic region and number of
candidate genes. Follow-up genome-wide linkage analysis with
additional genetic markers mapped a single QTL on chromosome
9 strongly linked to striatal CAG instability (Figure 3). A 95%
confidence interval was determined by using the 2-LOD-dropoff
method [35,86], narrowing down the implicated region to
approximately 5 Mb (chr9:107,982,655–113,057,967; GRCm38/
mm10). In addition to Mlh1, the implicated genomic region
contains numerous genes (,100).
(TIF)
Figure S7 Genetic variation at the Mlh1 locus between different
mouse strains. (A) Nonsynonymous polymorphisms identified at
the Mlh1 locus in the unstable C57BL/6NCrl, FVB/NCrl and
DBA/2J Hdh
Q111 strains, versus the more stable 129S2/SvPasCrlf
Hdh
Q111 strain. (B) Distribution of polymorphisms identified
between C57BL/6NJ, 129S1/SvImJ, FVB/NJ and DBA/2J
mouse strains at a 64 kb genomic region encompassing the Mlh1
gene (chr9:111,223,496–111,287,496; GRCm38/mm10) using
information from the Mouse Genomes Project [44,45]. Red,
nonsynonymous SNPs (nsSNPs); blue, SNPs; green, short indels;
purple, structural variants (SV).
(TIF)
Figure S8 Higher levels of somatic HTT CAG instability in B6,
FVB and DBA mice compared to 129. (A) Representative
GeneMapper profiles of HTT CAG repeat size distributions in
the tail and striatum of 10-week-old C57BL/6NCrl (B6), 129S2/
SvPasCrlf (129), FVB/NCrl (FVB) and DBA/2J (DBA) Hdh
Q111/+
mice, emphasizing the contribution of genetic background to
somatic HTT CAG repeat expansion, as previously described [17].
Tail: B6.Hdh
Q111/+, CAG117; 129.Hdh
Q111/+, CAG108; FVB.
Hdh
Q111/+, CAG122; DBA.Hdh
Q111/+, CAG115 (B) Quantification
of CAG instability index reveals significantly higher levels of
somatic HTT CAG instability in the striatum of B6, FVB and
DBA Hdh
Q111/+ mice compared to 129.Hdh
Q111/+ mice.
B6.Hdh
Q111/+, n=10, CAG116.961.2SD; 129.Hdh
Q111/+, n=12,
CAG110.961.2SD; FVB.Hdh
Q111/+, n=3, CAG123.762.1SD;
DBA.Hdh
Q111/+, n=3, CAG115.761.2SD; Bar graphs represent
mean 6SD; ***, p,0.001; ****, p,0.0001.
(TIF)
Figure S9 Comparison of Trex1 and Atrip genes in different
mouse strains. (A) Nonsynonymous polymorphisms identified at
the Trex1 and Atrip locus in the unstable B6, FVB and DBA
Hdh
Q111 strains, versus the more stable 129 Hdh
Q111 strain. (B)
Distribution of polymorphisms identified between B6, 129, FVB
and DBA mouse strains at a 16 kb genomic region containing the
Trex1 and Atrip genes (chr9:109,057,932–109,074,124; GRCm38/
mm10) using information from the Mouse Genomes Project
[44,45]. Red, nonsynonymous SNPs (nsSNPs); blue, SNPs; green,
short indels. (C) Quantification of Trex1 and Atrip mRNA levels in
the striatum of B6 and 129 10-week-old mice (n=3) by TaqMan-
based qRT-PCR. mRNA levels were determined relative to the
housekeeping gene Actb. Bar graphs represent mean 6SD.
(TIF)
Figure S10 Genetic variation at the Msh3 locus between
different mouse strains. (A) Nonsynonymous polymorphisms
identified at the Msh3 locus in B6, BALB, 129, FVB and DBA
mouse strains. (B) Distribution of genetic polymorphisms identified
between C57BL/6NJ, BALB/cJ, 129S1/SvImJ, FVB/NJ and
DBA/2J mouse strains across a region encompassing the Msh3
gene (chr13:92,201,881–92,365,003; GRCm38/mm10) using
information from the Mouse Genomes Project [44,45]. Red,
nonsynonymous SNPs (nsSNP); blue, SNPs; green, short indels;
purple, structural variants (SV).
(TIF)
Figure S11 Purified MutLa protein complexes used for cell-free
MMR assays. Human and mouse MLH1 proteins from B6 and
129 strains were independently co-expressed with human PMS2
protein in a baculovirus expression system. Purified MutLa
complexes were analyzed by polyacrylamide gel electrophoresis
and coomassie blue staining.
(TIF)
Figure S12 B6 and 129 MLH1 proteins show similar ability to
repair single base mismatches in a cell-free MMR assay. Repair of
a single base mismatch (G-T) containing 59 nick using HeLa or
HCT116 (MutLa-deficient) nuclear extracts complemented with
equal amounts of purified MutLa protein complexes: hMLH1.
WT-hPMS2, hMLH1.F192I-hPMS2, mMLH1.B6-hPMS2 or
mMLH1.129-hPMS2. Both B6 and 129 MLH1 proteins show
ability to repair the mismatch when in a complex with hPMS2,
with no overt difference in repair efficiency being observed
between the two (lanes 5 and 6). Likewise, introduction of the 129-
like F192I mutation in the human MLH1 protein had no
discernible effect in mismatch repair efficiency (lane 4).
(TIF)
Figure S13 Additional analyses of Mlh1 mRNA levels in B6
versus 129 strains. (A) Quantification of Mlh1 mRNA levels in the
striatum of B6 and 129 10-week-old mice (n=3) using TaqMan
assays probing 3 distinct regions of the primary Mlh1 transcript
(exons 4–5, 11–12, and 18–19) confirmed consistently reduced
Mlh1 mRNA levels in the striata of 129 mice, to approximately
50% of B6 levels. (B) The levels of Mlh1 mRNA (exons 11–12)
were also reduced in other tissues of 129 mice (cerebellum, liver,
jejunum and ileum), to between 25% and 50% of B6 levels (n=2).
Mlh1 mRNA levels were determined by TaqMan-based qRT-
PCR relative to the housekeeping gene Actb. Bar graphs represent
mean 6SD. **, p,0.01.
(TIF)
Figure S14 Additional analyses of MLH1 protein by western
blot. (A) Representative western blot used for quantification of
MLH1 protein levels in the striatum of B6.Mlh1
+/+, 129.Mlh1
+/+
and B6.Mlh1
+/2 10-week-old mice as represented in Figure 9C.
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(,60 kDa). The top panel of the blot was probed against MLH1,
while the bottom was probed against a-tubulin as loading control.
(B) MLH1 western blot of cortex samples from 10-week-old B6
and 129 mice on different Mlh1 genetic backgrounds.
(TIF)
Table S1 List of genetic markers used for QTL mapping.
(PDF)
Table S2 List of primers used.
(PDF)
Acknowledgments
We are grateful to Dr. Xiao-Jiang Li for providing the polyclonal EM48
antibody, to Dr. Winfried Edelmann for providing the Mlh1 null mice, to
Dr. Alba Guarne for helpful discussion, and to Dr. Marina Kovalenko and
Igor Dombrovsky for technical assistance.
Author Contributions
Conceived and designed the experiments: RMP AK KH PEC GML CEP
MJD VCW. Performed the experiments: RMP ED AK AL EL JSC GBP
CH KH TG JRG. Analyzed the data: RMP ED AK AL JSC GBP CH TG
GML CEP MJD VCW. Contributed reagents/materials/analysis tools:
AK MJD KH PEC. Wrote the paper: RMP GML CEP VCW.
References
1. The Huntington’s Disease Collaborative Research Group (1993) A novel gene
containing a trinucleotide repeat that is expanded and unstable on Huntington’s
disease chromosomes. Cell 72: 971–983.
2. Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, et al. (2012) CAG repeat
expansion in Huntington disease determines age at onset in a fully dominant
fashion. Neurology 78: 690–695.
3. Li JL, Hayden MR, Almqvist EW, Brinkman RR, Durr A, et al. (2003) A
genome scan for modifiers of age at onset in Huntington disease: The HD
MAPS study. Am J Hum Genet 73: 682–687.
4. Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, et al. (2004)
Venezuelan kindreds reveal that genetic and environmental factors modulate
Huntington’s disease age of onset. Proc Natl Acad Sci U S A 101: 3498–3503.
5. Gusella JF, MacDonald ME (2009) Huntington’s disease: the case for genetic
modifiers. Genome Med 1: 80.
6. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, et al. (1993)
Trinucleotide repeat length instability and age of onset in Huntington’s disease.
Nature genetics 4: 387–392.
7. Kennedy L, Evans E, Chen CM, Craven L, Detloff PJ, et al. (2003) Dramatic
tissue-specific mutation length increases are an early molecular event in
Huntington disease pathogenesis. Hum Mol Genet 12: 3359–3367.
8. Wheeler VC, Persichetti F, McNeil SM, Mysore JS, Mysore SS, et al. (2007)
Factors associated with HD CAG repeat instability in Huntington disease. J Med
Genet 44: 695–701.
9. Veitch NJ, Ennis M, McAbney JP, Shelbourne PF, Monckton DG (2007)
Inherited CAG.CTG allele length is a major modifier of somatic mutation
length variability in Huntington disease. DNA Repair (Amst) 6: 789–796.
10. Gonitel R, Moffitt H, Sathasivam K, Woodman B, Detloff PJ, et al. (2008) DNA
instability in postmitotic neurons. Proc Natl Acad Sci U S A 105: 3467–3472.
11. Swami M, Hendricks AE, Gillis T, Massood T, Mysore J, et al. (2009) Somatic
expansion of the Huntington’s disease CAG repeat in the brain is associated with
an earlier age of disease onset. Hum Mol Genet 18: 3039–3047.
12. Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE, et al. (1994)
Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in
brain and sperm. Nat Genet 6: 409–414.
13. De Rooij KE, De Koning Gans PA, Roos RA, Van Ommen GJ, Den Dunnen
JT (1995) Somatic expansion of the (CAG)n repeat in Huntington disease brains.
Hum Genet 95: 270–274.
14. Kaplan S, Itzkovitz S, Shapiro E (2007) A Universal Mechanism Ties Genotype
to Phenotype in Trinucleotide Diseases. PLoS Comput Biol 3: e235.
15. Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, et al. (1999)
Length-dependent gametic CAG repeat instability in the Huntington’s disease
knock-in mouse. Hum Mol Genet 8: 115–122.
16. Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, et al. (2000)
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in
medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum
Mol Genet 9: 503–513.
17. Lloret A, Dragileva E, Teed A, Espinola J, Fossale E, et al. (2006) Genetic
background modifies nuclear mutant huntingtin accumulation and HD CAG
repeat instability in Huntington’s disease knock-in mice. Hum Mol Genet 15:
2015–2024.
18. Wheeler VC, Lebel LA, Vrbanac V, Teed A, te Riele H, et al. (2003) Mismatch
repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.
Hum Mol Genet 12: 273–281.
19. Dragileva E, Hendricks A, Teed A, Gillis T, Lopez ET, et al. (2009)
Intergenerational and striatal CAG repeat instability in Huntington’s disease
knock-in mice involve different DNA repair genes. Neurobiol Dis 33: 37–47.
20. Kovalenko M, Dragileva E, St Claire J, Gillis T, Guide JR, et al. (2012) Msh2
Acts in Medium-Spiny Striatal Neurons as an Enhancer of CAG Instability and
Mutant Huntingtin Phenotypes in Huntington’s Disease Knock-In Mice. PLoS
One 7: e44273.
21. Manley K, Shirley TL, Flaherty L, Messer A (1999) Msh2 deficiency prevents in
vivo somatic instability of the CAG repeat in Huntington disease transgenic
mice. Nat Genet 23: 471–473.
22. van den Broek WJ, Nelen MR, Wansink DG, Coerwinkel MM, te Riele H, et al.
(2002) Somatic expansion behaviour of the (CTG)n repeat in myotonic
dystrophy knock-in mice is differentially affected by Msh3 and Msh6
mismatch-repair proteins. Hum Mol Genet 11: 191–198.
23. Savouret C, Brisson E, Essers J, Kanaar R, Pastink A, et al. (2003) CTG repeat
instability and size variation timing in DNA repair-deficient mice. EMBO J 22:
2264–2273.
24. Gomes-Pereira M, Fortune MT, Ingram L, McAbney JP, Monckton DG (2004)
Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic
mosaicism: implications for the mechanism of triplet repeat expansion. Hum
Mol Genet 13: 1815–1825.
25. Owen BA, Yang Z, Lai M, Gajec M, Badger JD, 2nd, et al. (2005) (CAG)(n)-
hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch
recognition. Nat Struct Mol Biol 12: 663–670.
26. Foiry L, Dong L, Savouret C, Hubert L, te Riele H, et al. (2006) Msh3 is a
limiting factor in the formation of intergenerational CTG expansions in DM1
transgenic mice. Hum Genet 119: 520–526.
27. Tome S, Holt I, Edelmann W, Morris GE, Munnich A, et al. (2009) MSH2
ATPase domain mutation affects CTG*CAG repeat instability in transgenic
mice. PLoS Genet 5: e1000482.
28. Bourn RL, De Biase I, Pinto RM, Sandi C, Al-Mahdawi S, et al. (2012) Pms2
Suppresses Large Expansions of the (GAA.TTC)(n) Sequence in Neuronal
Tissues. PLoS One 7: e47085.
29. Tome S, Manley K, Simard JP, Clark GW, Slean MM, et al. (2013) MSH3
Polymorphisms and Protein Levels Affect CAG Repeat Instability in
Huntington’s Disease Mice. PLoS Genet 9: e1003280.
30. Van Raamsdonk JM, Metzler M, Slow E, Pearson J, Schwab C, et al.( 2 0 0 7 )
Phenotypic abnormalities in the YAC128 mouse model of Huntington disease
are penetrant on multiple genetic backgrounds and modulated by strain.
Neurobiol Dis 26: 189–200.
31. Cowin RM, Bui N, Graham D, Green JR, Yuva-Paylor LA, et al. (2012) Genetic
background modulates behavioral impairments in R6/2 mice and suggests a role
for dominant genetic modifiers in Huntington’s disease pathogenesis. Mamm
Genome 23: 367–377.
32. Lee JM, Zhang J, Su AI, Walker JR, Wiltshire T, et al. (2010) A novel approach
to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol 4: 29.
33. Lee JM, Pinto RM, Gillis T, St Claire JC, Wheeler VC (2011) Quantification of
Age-Dependent Somatic CAG Repeat Instability in Hdh CAG Knock-In Mice
Reveals Different Expansion Dynamics in Striatum and Liver. PLoS One 6:
e23647.
34. Flint J, Valdar W, Shifman S, Mott R (2005) Strategies for mapping and cloning
quantitative trait genes in rodents. Nat Rev Genet 6: 271–286.
35. Lander ES, Botstein D (1989) Mapping mendelian factors underlying
quantitative traits using RFLP linkage maps. Genetics 121: 185–199.
36. Edelmann W, Cohen PE, Kane M, Lau K, Morrow B, et al. (1996) Meiotic
pachytene arrest in MLH1-deficient mice. Cell 85: 1125–1134.
37. Polosina YY, Cupples CG (2010) MutL: conducting the cell’s response to
mismatched and misaligned DNA. Bioessays 32: 51–59.
38. Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74:
681–710.
39. Lipkin SM, Moens PB, Wang V, Lenzi M, Shanmugarajah D, et al.( 2 0 0 2 )
Meiotic arrest and aneuploidy in MLH3-deficient mice. Nat Genet 31: 385–390.
40. Flores-Rozas H, Kolodner RD (1998) The Saccharomyces cerevisiae MLH3
gene functions in MSH3-dependent suppression of frameshift mutations. Proc
Natl Acad Sci U S A 95: 12404–12409.
41. Charbonneau N, Amunugama R, Schmutte C, Yoder K, Fishel R (2009)
Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3
mismatch repair. Cancer Biol Ther 8: 1411–1420.
42. Cannavo E, Marra G, Sabates-Bellver J, Menigatti M, Lipkin SM, et al.( 2 0 0 5 )
Expression of the MutL homologue hMLH3 in human cells and its role in DNA
mismatch repair. Cancer Res 65: 10759–10766.
43. Tome S, Simard JP, Slean MM, Holt I, Morris GE, et al. (2013) Tissue-specific
mismatch repair protein expression: MSH3 is higher than MSH6 in multiple
mouse tissues. DNA Repair (Amst) 12: 46–52.
44. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, et al. (2011) Mouse
genomic variation and its effect on phenotypes and gene regulation. Nature 477:
289–294.
Mlh1 and Mlh3 Are Required for CAG Expansions
PLOS Genetics | www.plosgenetics.org 18 October 2013 | Volume 9 | Issue 10 | e100393045. Yalcin B, Wong K, Agam A, Goodson M, Keane TM, et al. (2011) Sequence-
based characterization of structural variation in the mouse genome. Nature 477:
326–329.
46. Hall MC, Shcherbakova PV, Kunkel TA (2002) Differential ATP binding and
intrinsic ATP hydrolysis by amino-terminal domains of the yeast Mlh1 and
Pms1 proteins. J Biol Chem 277: 3673–3679.
47. Consortium TU (2012) Reorganizing the protein space at the Universal Protein
Resource (UniProt). Nucleic Acids Research 40: D71–D75.
48. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010)
A method and server for predicting damaging missense mutations. Nat Methods
7: 248–249.
49. Zhang Y, Yuan F, Presnell SR, Tian K, Gao Y, et al. (2005) Reconstitution of
59-directed human mismatch repair in a purified system. Cell 122: 693–705.
50. Panigrahi GB, Slean MM, Simard JP, Pearson CE (2012) Human mismatch
repair protein hMutLalpha is required to repair short slipped-DNAs of
trinucleotide repeats. J Biol Chem 287(50):41844–50.
51. Panigrahi GB, Slean MM, Simard JP, Gileadi O, Pearson CE (2010) Isolated
short CTG/CAG DNA slip-outs are repaired efficiently by hMutSbeta, but
clustered slip-outs are poorly repaired. Proc Natl Acad Sci U S A 107: 12593–
12598.
52. Klungland A, Lindahl T (1997) Second pathway for completion of human DNA
base excision-repair: reconstitution with purified proteins and requirement for
DNase IV (FEN1). EMBO J 16: 3341–3348.
53. Cortez D, Guntuku S, Qin J, Elledge SJ (2001) ATR and ATRIP: partners in
checkpoint signaling. Science 294: 1713–1716.
54. Goula AV, Berquist BR, Wilson DM, 3rd, Wheeler VC, Trottier Y, et al. (2009)
Stoichiometry of base excision repair proteins correlates with increased somatic
CAG instability in striatum over cerebellum In Huntington’s disease transgenic
mice. PLoS Genet 5: e1000749.
55. Goula AV, Pearson CE, Della Maria J, Trottier Y, Tomkinson AE, et al. (2012)
The nucleotide sequence, DNA damage location, and protein stoichiometry
influence the base excision repair outcome at CAG/CTG repeats. Biochemistry
51: 3919–3932.
56. Lopez Castel A, Tomkinson AE, Pearson CE (2009) CTG/CAG repeat
instability is modulated by the levels of human DNA ligase I and its interaction
with proliferating cell nuclear antigen: a distinction between replication and
slipped-DNA repair. J Biol Chem 284: 26631–26645.
57. Liu Y, Prasad R, Beard WA, Hou EW, Horton JK, et al. (2009) Coordination
between polymerase beta and FEN1 can modulate CAG repeat expansion. J Biol
Chem 284: 28352–28366.
58. Lin Y, Wilson JH (2009) Diverse effects of individual mismatch repair
components on transcription-induced CAG repeat instability in human cells.
DNA Repair (Amst) 8: 878–885.
59. Ezzatizadeh V, Pinto RM, Sandi C, Sandi M, Al-Mahdawi S, et al. (2012) The
mismatch repair system protects against intergenerational GAA repeat instability
in a Friedreich ataxia mouse model. Neurobiol Dis 46: 165–171.
60. Lang WH, Coats JE, Majka J, Hura GL, Lin Y, et al. (2011) Conformational
trapping of mismatch recognition complex MSH2/MSH3 on repair-resistant
DNA loops. Proc Natl Acad Sci U S A 108: E837–844.
61. Sugawara N, Paques F, Colaiacovo M, Haber JE (1997) Role of Saccharomyces
cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced
recombination. Proc Natl Acad Sci U S A 94: 9214–9219.
62. Kadyrov FA, Dzantiev L, Constantin N, Modrich P (2006) Endonucleolytic
function of MutLalpha in human mismatch repair. Cell 126: 297–308.
63. Pluciennik A, Burdett V, Baitinger C, Iyer RR, Shi K, et al. (2013) Extrahelical
(CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen
loading and MutLalpha endonuclease activation. Proc Natl Acad Sci U S A 110:
12277–12282.
64. Edelbrock MA, Kaliyaperumal S, Williams KJ (2013) Structural, molecular and
cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage
signaling and other noncanonical activities. Mutat Res 743–744:53–66.
65. Pena-Diaz J, Jiricny J (2012) Mammalian mismatch repair: error-free or error-
prone? Trends Biochem Sci 37: 206–214.
66. Kolas NK, Cohen PE (2004) Novel and diverse functions of the DNA mismatch
repair family in mammalian meiosis and recombination. Cytogenet Genome
Res 107: 216–231.
67. Peng M, Litman R, Xie J, Sharma S, Brosh RM, Jr., et al. (2007) The FANCJ/
MutLalpha interaction is required for correction of the cross-link response in
FA-J cells. EMBO J 26: 3238–3249.
68. Polosina YY, Cupples CG (2010) Wot the ’L-Does MutL do? Mutat Res 705:
228–238.
69. Slean MM, Panigrahi GB, Ranum LP, Pearson CE (2008) Mutagenic roles of
DNA ‘‘repair’’ proteins in antibody diversity and disease-associated trinucleotide
repeat instability. DNA Repair (Amst) 7: 1135–1154.
70. Pena-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Boran M,
et al. (2012) Noncanonical mismatch repair as a source of genomic instability in
human cells. Mol Cell 47: 669–680.
71. Shelbourne PF, Keller-McGandy C, Bi WL, Yoon SR, Dubeau L, et al. (2007)
Triplet repeat mutation length gains correlate with cell-type specific vulnerability
in Huntington disease brain. Hum Mol Genet 16: 1133–1142.
72. Wei K, Kucherlapati R, Edelmann W (2002) Mouse models for human DNA
mismatch-repair gene defects. Trends Mol Med 8: 346–353.
73. Peltomaki P, Vasen H (2004) Mutations associated with HNPCC predisposition
– Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20: 269–
276.
74. Chen PC, Dudley S, Hagen W, Dizon D, Paxton L, et al. (2005) Contributions
by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor
suppression in the mouse. Cancer Res 65: 8662–8670.
75. Plaschke J, Preussler M, Ziegler A, Schackert HK (2012) Aberrant protein
expression and frequent allelic loss of MSH3 in colorectal cancer with low-level
microsatellite instability. Int J Colorectal Dis 27: 911–919.
76. Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, et al. (2007) OGG1
initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature
447: 447–452.
77. Hubert L, Jr., Lin Y, Dion V, Wilson JH (2011) Xpa deficiency reduces CAG
trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1.
Hum Mol Genet 20: 4822–4830.
78. Mollersen L, Rowe AD, Illuzzi JL, Hildrestrand GA, Gerhold KJ, et al.( 2 0 1 2 )
Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat
instability in R6/1 mice. Hum Mol Genet 21: 4939–4947.
79. Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, et al. (1997) Instability
of highly expanded CAG repeats in mice transgenic for the Huntington’s disease
mutation. Nat Genet 15: 197–200.
80. Kirby A, Kang HM, Wade CM, Cotsapas C, Kostem E, et al. (2010) Fine
mapping in 94 inbred mouse strains using a high-density haplotype resource.
Genetics 185: 1081–1095.
81. Lander ES, Green P, Abrahamson J, Barlow A, Daly MJ, et al.( 1 9 8 7 )
MAPMAKER: an interactive computer package for constructing primary
genetic linkage maps of experimental and natural populations. Genomics 1:
174–181.
82. Paterson AH, Lander ES, Hewitt JD, Peterson S, Lincoln SE, et al. (1988)
Resolution of quantitative traits into Mendelian factors by using a complete
linkage map of restriction fragment length polymorphisms. Nature 335: 721–726.
83. Lincoln SE, Daly MJ, Lander ES (1993) Constructing Genetic Linkage Maps
with MAPMAKER/EXP Version 3.0: A Tutorial and Reference Manual.
Whitehead Institute for Biomedical Research Technical Report, 3rd edition.
84. Lincoln SE, Daly MJ, Lander ES (1993) Mapping Genes Controlling
Quantitative Traits Using MAPMAKER/QTL Version 1.1: A Tutorial and
Reference Manual. Whitehead Institute for Biomedical Research Technical
Report, 2nd edition.
85. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for
interpreting and reporting linkage results. Nat Genet 11: 241–247.
86. Ooijen J (1992) Accuracy of mapping quantitative trait loci in autogamous
species. Theoretical and Applied Genetics 84: 803–811.
87. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, et al. (1999) Nuclear and
neuropil aggregates in Huntington’s disease: relationship to neuropathology.
J Neurosci 19: 2522–2534.
88. Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, et al. (2010) Huntingtin
facilitates polycomb repressive complex 2. Hum Mol Genet 19: 573–583.
89. Li GM, Modrich P (1995) Restoration of mismatch repair to nuclear extracts of
H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl
Acad Sci U S A 92: 1950–1954.
90. Gammie AE, Erdeniz N, Beaver J, Devlin B, Nanji A, et al. (2007) Functional
characterization of pathogenic human MSH2 missense mutations in Saccharo-
myces cerevisiae. Genetics 177: 707–721.
91. Aldred PM, Borts RH (2007) Humanizing mismatch repair in yeast: towards
effective identification of hereditary non-polyposis colorectal cancer alleles.
Biochem Soc Trans 35: 1525–1528.
92. Takahashi M, Shimodaira H, Andreutti-Zaugg C, Iggo R, Kolodner RD, et al.
(2007) Functional analysis of human MLH1 variants using yeast and in vitro
mismatch repair assays. Cancer Res 67: 4595–4604.
93. Trojan J, Zeuzem S, Randolph A, Hemmerle C, Brieger A, et al.( 2 0 0 2 )
Functional analysis of hMLH1 variants and HNPCC-related mutations using a
human expression system. Gastroenterology 122: 211–219.
94. Pfaffl MW (2001) A new mathematical model for relative quantification in real-
time RT-PCR. Nucleic Acids Res 29: e45.
95. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, et al.
(2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111)
striatal cells. Hum Mol Genet 9: 2799–2809.
96. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, et al. (2011) Fast, scalable
generation of high-quality protein multiple sequence alignments using Clustal
Omega. Mol Syst Biol 7: 539.
97. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ (2009) Jalview
Version 2–a multiple sequence alignment editor and analysis workbench.
Bioinformatics 25: 1189–1191.
98. Pearson CE, Ewel A, Acharya S, Fishel RA, Sinden RR (1997) Human MSH2
binds to trinucleotide repeat DNA structures associated with neurodegenerative
diseases. Hum Mol Genet 6: 1117–1123.
Mlh1 and Mlh3 Are Required for CAG Expansions
PLOS Genetics | www.plosgenetics.org 19 October 2013 | Volume 9 | Issue 10 | e1003930